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CHAPTER I
INTRODUCTION

1.1

Free Radical Formation and Antioxidant System in Human Erythrocytes
Free radicals and reactive oxygen species, such as superoxide (0 2 -), hydroxyl radical

('OH), alkyl radical (L' or R·), alkoxyl radical (LO· or RO·), peroxyl radical (LOO· or ROO·),
thiyl radical (RS·), thiyl peroxy (RSOO·), hydrogen peroxide (H 20 2 ), hydroperoxide (LOOH
or ROOH), hypochlorous acid (HOCl), and singlet oxygen ( 10 2 ), are oxidants. They are
generated endogenously and exogenously throughout our lifetime. Endogenous sources of
oxidants are from all the aerobic cellular metabolism such as mitochondrial respiration,
phagocytosis, hemoglobin auto-oxidation, and the activities of some oxidases, dehydrogenases,
and peroxidases. Examples of external sources of oxidants are natural dietary constituents,
UV radiation, hyperoxic air, chemicals, drugs, and environmental pollutants such as
automotive exhaust, cigarette smoke, and ozone (Ames, 1983; Cerutti, 1985; Cross et al., 1987;
Halliwell & Gutteridge, 1989).
In the past decade, it has become increasingly evident that oxidants are involved in
a variety of human diseases as they play roles in cellular destruction: poisoning vital enzymes;
bashing nicks, crosslinks, and disruptive additions or adducts into DNA; inciting normally
harmless chemicals to toxicants and carcinogens; tearing apart polysaccharides; and touching
off peroxidase chain reactions that unravel membranes (Hooper, 1989; Halliwell, 1991). With
the recognition that oxidative damage is an unavoidable part of our life, there has been
growing interest in elucidating the mechanism of the cellular antioxidant system. Aerobic

I

2

organisms are endowed with various antioxidants including enzymes and small biological
molecules. In addition, antioxidant vitamins are taken up from nutrient diet. Normally,
metabolic activity is able to control or prevent adverse effects of oxidants. The susceptibility
of a given organism to oxidative stress is a function of the overall balance between the factors
that exert oxidative stress and those that exhibit antioxidant capability. Therefore, oxidative
damage can be described as a consequence of excessive oxidative stress or insufficient
antioxidant potential (Chow, 1979; Sies, 1991).
Red blood cells (RBC), as oxygen carriers in the body, are especially vulnerable to the
potential hazards of an aerobic environment since they are laden with iron, a transition metal
conducive to oxygen radical formation, and their membrane with high polyunsaturated lipid
are exposed to an endless flux of oxygen. The oxidant challenge almost certainly begins with
generation of 0 2 -, for which the normal daily oxidation of hemoglobin in circulating
erythrocytes serves as a relentless source (Chiu et al., 1982; Caughey & Watkins, 1985). Then,
0 2 - is converted into H 20 2 by enzymatic or non-enzymatic dismutation. The presence of

both 0 2 - and H 2 0 2 creates the possibility for appearance of ·OH, as classically indicated by
the Haber-Weiss reaction:

This equation actually is the sum of following two reactions in which a catalytic iron cycles
between two valence states:

Fe+ 3 + 0 2 -

--+

Fe+ 2 + 0 2

Thus, the reaction of H 20 2 with ferrous iron is the actual ·OH generating step, known as the
Fenton reaction.

Due to its extreme reactivity, ·OH can damage almost any biological

molecule it encounters. Attack of ·OH on biological molecules can proceed by addition,
hydrogen atom abstraction, or electron transfer reactions (Halliwell & Gutteridge, 1989). In
many cases, carbon-centered radicals (L") are produced that can react with 0 2 to give LOO·.

3

L-H +·OH
L· + 0 2

--+

--+

L- + H 2 0

LOO·

Formation of LOO· is a major chain-propagating step in lipid peroxidation. The process of
lipid peroxidation has been shown to be associated with the loss of membrane polyunsaturated
fatty acids (Dodge et al., 1966; Jacob & Lux, 1968), the formation of hydroperoxides and
other secondary products (Stocks & Dormandy, 1971 ), the cross-linking of membrane proteins
(Haest et al., 1977; Palek & Liu, 1979), and the decreased activity of membrane enzymes
(O'Malley et al., 1966; Buckley et al., 1975; Chow, 1978).

The changes in lipids, proteins,

and enzyme activities of red cell membranes after peroxidant injury inevitably lead to changes
in membrane structure and function, and ultimately cause cell hemolysis.
Oxidative damage to hemoglobin also has been shown to cause changes in hemoglobin
structure and function (Jacob, 1970; Nagel & Ranney, 1973; Rachmilewitz, 1974). Such
changes ultimately result in hemoglobin denaturation and precipitation inside the red cells as
Heinz bodies. The physical presence of these inclusion bodies reduces red cell deformability
and contributes to the hemolytic event (Rifkind, 1965; Jacob et al., 1968; Chiu et al., 1982).
In addition to being a target for oxidative damage, the mature human erythrocyte is
an anucleated cell that lacks protein synthesis machinery and is therefore unable to replace
damaged components. However, perhaps as an evolutionary consequence of this deficiency,
the erythrocyte devotes much of its metabolic activity toward defense against oxidant
challenge.
Erythrocyte antioxidant mechanisms may be divided into two parts: detoxification
and damage repair (Hebbel, 1986). The systems that function to detoxify oxidants include
superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione
(GSH), and vitamin E.

The systems considered for damage repair are the hexose

monophosphate shunt (also called pentose phosphate shunt) and other enzymes such as
methemoglobin reductase, glutathione reductase, and glutathione-S-transferase. It is generally
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considered that the primary and major antioxidant systems in RBC are the detoxification
systems, since they are involved in the direct elimination of oxidants (Chiu et al., 1982; Sun,
1990). The other systems exist to repair damage by decreasing methemoglobin and peroxide
levels, and to the help detoxification system by maintaining a steady supply of reducing
equivalents for the primary antioxidant enzymes. A brief review of the known and proposed
mechanisms about some of major antioxidants is presented in Appendix II.

Details of

providing reducing equivalents in reactions that are critical for primary antioxidants are
presented in the Discussion section.

1.2

Nitroxide Spin Label
Nitroxide spin label is a synthetic organic compound containing the nitroxide group

(>N-0") with an unpaired electron located close to the oxygen atom. Due to the sterically
hindered structure (four alkyl groups around it), the unpaired electron in nitroxide spin labels
is relatively stable in both solution and biological environments. Electron paramagnetic
resonance (EPR) spectra of nitroxide spin labels are very sensitive to the rate of molecular
motion. The rapid isotropically tumbling nitroxide gives a spectrum of three sharp lines. If
the rate of molecular motion decreases, differential broadening of the three-line nitroxide
spectrum occurs. Both the nitroxide chemical character and EPR techniques render nitroxide
spin labels useful as reporters for molecular studies of labeled systems. Nitroxides have been
used extensively to study motion in membranes and macromolecules (Likhtenstein, 1976;
Berliner, 1979), membrane surface and transmembrane potentials (Mehlhorn & Packer, 1979;
Mehlhorn & Probst, 1982), and oxygen concentration in cells (Lai et al., 1982; Morse II &
Swartz, 1985). Nitroxides are also under active investigation as metabolically responsive
contrast or imaging agents for in vivo nuclear magnetic resonance (NMR) or EPR imaging
(Brasch, 1983; Keana et al., 1987; Sentjurc et al., 1991). All of these uses have led to an
increased need for nitroxides with differing chemical properties, especially in regard to their
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distribution and reduction rate in biological systems.

Spin label reductions of various

nitroxides to diamagnetic hydroxylamines (Chen & Swartz, 1989) have been found to depend
upon many factors including the characteristics of the spin label (Swartz et al., 1986; Eriksson

et al., 1986; Perussi et al., 1988; Belkin et al., 1987), the system investigated (Stier & Reitz,
1971; Giotta & Wang, 1972; Quintanilha & Packer, 1977; Baldassare et al., 1974; Couet et al.,
1985; Chen et al., 1988) and the environmental conditions with particular emphasis on oxygen
concentration (Swartz et al., 1986; Keana et al., 1987; Chen et al., 1989).
Fatty acid nitroxide spin labels with the nitroxide moiety on the acyl chain are
Iipophilic and able to position themselves into the bilayer of membrane. The reduction of
fatty acid nitroxide spin labels has been studied in many biological systems such as
mitochondria (Quintanilha & Packer, 1977; Mehlhorn & Packer, 1982), Escherichia coli
membrane vesicles (Baldassare et al., 1974), mouse thymus-bone marrow cells and Chinese
hamster ovary cells (Chen et al., 1988). It is generally believed that enzymatic reductions by
the electron transfer systems are involved in these tissues and cells.
For human erythrocytes, the reduction of some water-soluble nitroxide spin labels
have also been observed (Ross & McConnell, 1975; Craescu et al., 1982; Eriksson et al., 1986;
Branca et al., 1988; Mehlhorn, 1991). It has been suggested that ascorbate and glutathione are
possible intracellular reductants for the water-soluble nitroxides.

However, it has been

reported that fatty acid spin labels are stable in normal mice erythrocytes over a time period
of 30 min (Deslauriers et al., 1987).
We have monitored the EPR signals of fatty acid spin labels in human normal
erythrocyte for a longer period of time under somewhat different conditions, and observed
nitroxide reduction with a pseudo first-order initial rate constant of about 4 x 10-3 /min (Fung
& Zhang, 1990). This reduction reflects antioxidant activity toward nitroxide radicals in cell

membrane and thus can be used to monitor the capacity of intracellular antioxidant system
for radicals in human erythrocyte membranes.
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1.3

Overview of Sickle Cell Disease Studies
The existence of sickle-shaped erythrocytes in human blood was first discovered by

Herrick in the early part of this century (Herrick, 1910). Afterwards, many case reports and
small series from which most of the clinical features and pathological changes in the disease
have emerged. In general, the clinical manifestations of this disease are chronic hemolytic
anemia and occasional painful crisis resulting from tissue infarct caused by vascular occlusion.
The alteration of hemoglobin molecule in sickle cells was identified with electrophoretic
mobility by Pauling and his colleagues in 1949 (Pauling et al., 1949). Then, Ingram (1956)
showed that the molecular abnormality was due to the substitution of a single amino acid,
valine for glutamic acid residue at the sixth position of hemoglobin f3 chain. In the last
quarter of a century, understanding of the molecular pathophysiology, diagnosis, and
treatment of sickle cell disease has come from striking results in the application of x-ray
diffraction, electron microscopy, thermodynamic and kinetic analyses, NMR spectroscopy,
restriction enzyme mapping, and differential gene expression studies (Schechter et al., 1987).
The deoxygenated sickle hemoglobin (HbS) has an abnormally low solubility and
aggregates to form long fibers, which deform red cells to give their sickle shape (Dobler &
Berdes, 1968; Edelstein et al., 1973). Upon oxygenation, the aggregated HbS reverts to the
soluble state and the majority of sickled cells regain the normal biconcave shape. However,
a fraction of the sickled cells retain the abnormal morphology even under fully oxygenated
condition (Berdes and Dobler, 1969). These irreversibly sickled cells (ISC) are dehydrated
cells with increased intracellular hemoglobin concentrations (Clark et al., 1978) and increased
internal viscosity (Chien et al., 1970; Kaul et al., 1983). They are much less deformable than
normal shaped cells (Clark et al., 1980) and may contribute to the initiation of microvascular
occlusion in sickle cell disease. It is generally believed that the ISC abnormal morphology is
the result of an irreversible alteration of their membrane.

Evidence is provided by the

findings that ISC maintain their distorted shapes upon re-oxygenation even after the
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intracellular hemoglobin is removed (Lux et al., 1976; Smith et al., 1982). Since the 1950s,
many abnormalities in sickle cell membranes, such as increased cation leak (Tosteson et al.,
1952; Glader & Nathan, 1978; Joiner et al., 1986; Joiner, 1990), increased calcium content
(Eaton et al., 1973; Bookchin & Lew, 1980), altered phospholipid distribution and membrane
organization (Lubin & Chiu, 1981; Wagner et al., 1985; Zachowski et al., 1985; Mohandas et

al., 1985; Choe et al., 1986; Middelkoop et al., 1988), decreased activity of ca+ 2 -Mg+ 2
ATPase (Dixon & Winslow, 1981; Niggli et al., 1982; Leclerc et al., 1987), abnormal protein
phosphorylation (Dzandu & Johnson, 1980; Johnson et al., 1986) and methylation (Ro et al.,
1981), have been detected.
Besides its low solubility, HbS is unstable in terms of giving rise to denatured
hemoglobin (Asakura et al., 1974). This HbS instability has been directly demonstrated by
increased autoxidation of HbS (Hebbel et al., 1988). The denaturation of HbS is believed to
occur initially through oxidation to methemoglobin, followed by further oxidation to
hemichromes and globin. HbS and hemichromes formed from HbS have a high affinity for
binding to cell membrane (Fischer et al., 1975; Fung et al., 1983). The shift of iron from
cytoplasm to membrane leads to the exposure of the membrane to oxidative species such as
superoxide, peroxide, and hydroxyl radicals, which are the products of heme-iron
autoxidation and subsequent reactions. It has been reported that sickle RBC from sickle cell
anemia patients spontaneously generate double amounts of oxygen radicals compared with
normal RBC (Hebbel et al., 1982). Increased oxidation of lipids (Das & Nair, 1980; Chiu et

al., 1982) and skeletal proteins constituents (Rank et al., 1984; 1985) of sickle cell membrane
has also been demonstrated. Therefore it is generally believed that sickle cell membranes are
particularly susceptible to oxidant damage.
On the other hand, some of the antioxidant systems in sickle cells appear to be
abnormal. Generally, individual antioxidant activity were measured in the sickle cell anemia
(SCA) studies. For example, it has been reported that SCA patients have increased GPx
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activities (Chiu and Lubin, 1979; Beretta et al., 1983; Lachant et al., 1983), but decreased SOD
activities (Schacter et al., 1985; 1988), or decreased GPx activities (Das and Nair, 1980) and
increased SOD activities (Das and Nair, 1980; Beretta et al., 1983). It is also reported that
sickle cells have abnormal pyridine nucleotide contents and impaired methemoglobin
reduction (Zerez et al., 1988; 1990). However, it is difficult to detect oxidative species such
as superoxide, peroxide and hydroxyl radicals in membranes due to their extreme reactivity
or their very short life times. Therefore, it is difficult to assess the effectiveness of the
cellular antioxidants on radicals in membranes. In addition, the antioxidants exert concerted
efforts toward oxidant stress. The decrease of one antioxidant may be compensated by the
increase of another antioxidant.
In this work, the spin label reduction method has been applied to sickle erythrocytes
to study the radical reduction efficiency in membranes of sickle cells as compared with
normal cells. Besides the measurement of spin label reduction in normal and sickle cells, the
concentrations of several major antioxidants, such as SOD, CAT, GPx, vitamin E, and
ascorbate, have been determined on the same samples used for the spin label studies in order
to determine the effects of these individual antioxidants on the radical reduction rates in
erythrocyte membranes.

CHAPTER II

MATERIALS AND METHODS

2.1

Chemicals
All chemicals used for this dissertation work were of reagent grade.
Fatty acid spin probe, 5-doxylstearic acid (5-DSA), was purchased from either Syva

Research Chemicals (Palo Alto, CA) or-Aldrich Chemical Co., Inc. (Milwaukee, WI) and used
without further purification.

OH

5-DSA
Sodium phosphate (NaH 2P0 4 and Na 2HP0 4), sodium chloride (NaCl), potassium chloride
(KCl), potassium hydroxide (KOH), and sodium hydroxide (NaOH) were obtained from
Fisher Scientific (Pittsburgh,

PA);

potassium

phosphate (KH 2 P0 4 and

K 2 HP0 4 ),

ethylenediamine tetraacetic acid (EDT A), bovine serum albumin (BSA), L-ascorbic acid
(vitamin C), glutathione (reduced form, GSH), superoxide dismutase (EC 1.15.1.1 ),
glutathione peroxidase (EC 1.11.1.9), ascorbate oxidase (EC 1.10.3.3), xanthine oxidase (EC
1.1.3.22), formaldehyde dehydrogenase (EC 1.2.1.1), formaldehyde (HCOH), xanthine, /3nicotinamide adenine dinucleotide phosphate (reduced form, NADPH), /3-nicotinamide
adenine dinucleotide (reduced form, NADH), ,8-nicotinamide adenine dinucleotide (NAD),
cysteine, N-ethylmaleimide (NEM), and hydrogen peroxide (H 20 2 ) from Sigma Chemical Co.
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(St. Louis, MO); D-(+)-glucose, ferric chloride (FeC1 3 ), 2,2'-dipyridyl (a,a'-dipyridyl),
trichloroacetic acid (CC1 3 C02 H), and phosphoric acid (H 3 P0 4 ) from Aldrich Chemical Co.,
Inc. (Milwaukee, WI); magnesium chloride (MgC1 2 ) from J. T. Baker Chemical Co.
(Phillipsburg, NJ); glutathione reductase (GR) from Calbiochem Corporation (La Jolla, CA);
katalase (catalase) from Boehringer Mannheim GmbH (Germany); d-a-tocopherol (vitamin
E) from Eastman Kodak Co. (Rochester, NY); silicone liquid (200 fluid) from Dow Corning
Corporation (Midland, MI); super-heme buffer, lysate reagent, and cellulose acetate plates
from Helena Laboratories (Beaumont, TX); absolute ethyl alcohol (200 proof pure ethanol)
from Aaper Alcohol & Chemical Co. (Shelbyville, KY).

2.2

Red Blood Cells
Human adult normal RBC were obtained from a local blood bank (Red

Cross/LifeSource), with CPDA-1 or ADSOL used for anticoagulant. Sickle RBC samples
from adult homozygous patients with sickle cell anemia disease were collected into
heparinized, EDT A, or citrate-coated tubes at either Mount Sinai Hospital in Chicago or the
George Washington University in Washington, D.C .. Hemoglobin (Hb) electrophoresis was
performed on each sickle blood sample in our laboratory and only the blood samples with over
90 % sickle Hb were used for this study.
The RBC were washed with an isotonic buffer solution of either 5 mM sodium
phosphate buffer with 150 mM NaCl at pH 8.0 (phosphate buffer saline, PBS), or sodium
phosphate buffer (1.4 mM NaH 2 P0 4 and 8.6 mM Na 2 HP0 4 ) with 135 mM NaCl, 5 mM KCl,
and 11 mM glucose at pH 7.4 and osmolality 290

~

300 mmol/kg (buffered saline with

potassium and glucose, BSKG). The buffer solutions were gassed with carbon monoxide (CO)
at 4 °C for at least 30 min before use. To about 5 ml of packed RBC, 35 ml of PBS were
added and mixed gently with a plastic pipette, then centrifuged at 4,000 rpm (I ,912 g) for 4
min with a Sorvall RT6000B refrigerated centrifuge. Supernatant containing plasma materials
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and buffy coat was removed by aspiration after the centrifugation. The washing of RBC with
PBS was repeated two more times, and all steps were performed at 4 °C.
The washed blood cells were checked optically, using optical cells with very narrow
light paths (0.01 mm), at wavelengths of 540 nm and 569 nm (Antonini & Brunori, 1971) to
ensure that the Hb molecules inside the cells were fully CO-liganded. For cells that needed
to be oxygenated, 0 2 -gassed buffers, instead of CO-gassed buffers, were used to wash the
RBC. Again to ensure all Hb molecules inside the cells were 0 2 -liganded, optical spectra of
these cells at 541 nm and 577 nm (Antonini & Brunori, 1971) were obtained.

2.3

Spin-Labeled RBC
5-DSA was stored in ethanol solution at a concentration of about 0.5 mg/ml. Spin

labels in ethanol (1.0 ml) were transferred into a small brown container, and ethanol was
evaporated to dryness with nitrogen gas at room temperature to give a thin film of spin labels
on the container walls.

About 10 ml of fatty-acid-free bovine serum albumin (BSA)

(2.2 mg/ml) in PBS solution was added to the container. The solution was stirred for at least
4 hr at room temperature to give a spin-labeled BSA (BSA*) solution, with a spin label
concentration of about 5 x 10- 5 mM, as determined by EPR measurements.
5-DSA were introduced into RBC membranes by mixing 50 µl packed RBC
(hematocrit > 95 %) with 1.0 ml of the BSA* solution for about 30 min at 4 °C, then the
mixture was washed with cold PBS again to remove excess BSA*. To avoid echinocyte
formation (Hubbell & McConnell, 1969; Shiga et. al., 1977), the fatty acid spin labels were
not mixed directly with red blood cells.
The spin-labeled cells (about 20 µl) were packed in small hematocrit capillaries, which
were used as EPR sample tubes, by a micro-hematocrit centrifuge for 3 min at 4 °C. The
heights of the packed cells in the hematocrit tubes were at least 2 cm to ensure proper EPR
measurements.
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2.4

Lysate
A centrifuge tube containing washed, CO-gassed RBC with hematocrit values greater

than 95 % was immersed in liquid nitrogen for about 30 sec to allow complete freezing of the
cells, followed by immersion in a water bath at room temperature for about 2 min. Then the
thawed sample was centrifuged for 10 min at 16,000 rpm (30,590 g) with a Sorvall RC-5B
refrigerated centrifuge, using a SS-34 rotor. The supernatant in the tube was removed, stored
on ice and used as membrane-free cell lysate.

2.5

Hemoglobin
Hb was prepared by others in our laboratory according to the method of Dozy et al.

(1968). In brief, washed normal RBC were lysed in 2 volumes of cold deionized water with
gently stirring for 30 min at 4 °C. To every 80 ml Hb solution, 20 ml of cold ammonium
sulfate solution (76.7 g/100 ml H 20, pH= 7.0) were added, and continuously stirred for an
additional 30 min at 4 °C. The mixture was then centrifuged at 12,000 rpm (17 ,210 g) for 10
min.

After centrifugation, all the supernatant portions were pooled, and the residues

containing the membrane and other precipitates at the bottom of the centrifuge tubes were
discarded. The lysate was concentrated to a small volume and desalted by dialysis in 50 mM
Tris buffer (pH 8.3).

The dialyzed lysate was then loaded on an ion-exchange column

containing DEAE Sephadex resin equilibrated with Tris buffer, pH 8.3. Separation of the
different Hb was performed by decreasing pH gradient from 8.3 to 7.0 with the Tris buffer
and monitoring the absorbance at 280 nm with an ISCO UV monitor. The adult Hb (HbA)
fraction was collected and pooled according to the peak under the chromatogram. The
purified HbA was CO gassed, frozen dropwise into liquid nitrogen, and stored in a deep
freezer ( - 70 °C).

13
2.6

Membranes and Spin-Labeled Membranes
White membrane ghosts were prepared from washed RBC according to a published

method (Steck & Kaut, 1974). Cells were lysed in 5 mM sodium phosphate buffer at pH 8.0
(5P8) and followed by centrifugation at 16,000 rpm (30,590 g) for 10 min. The supernatant
was removed with a tap aspirator. During aspiration, the centrifuge tube was tipped and
rotated on its axis so that the loosely packed ghosts slide away from a small hard button, rich
in contaminating proteases, which may then be aspirated. Two or three more identical wash
cycles were performed to get white membrane ghosts. Subsequently, the white membrane was
washed and re-suspended in PBS. Membrane concentrations were calculated according to
their absorbance at 280 nm and expressed by protein concentrations, which were determined
by modified Lowry methods (Peterson, 1977).
Spin-labeled membranes (Mb*) were obtained by mixing 1.25 ml of white membranes
(about 4.3 mg/ml) with 0.75 ml of 5-DSA in PBS for 30 min at 4 °C, and the mixture was
washed 3 times with cold CO-gassed PBS to remove excess free spin labels. The 5-DSA in
PBS was prepared by evaporating 1.0 ml stock spin label ethanol solution to dryness and
adding 1.0 ml PBS to the container with stirring at room temperature for about 1 hr. Spin
labels were not transferred to the membrane via BSA* solution, as was done for the RBC
samples, since BSA* strongly adsorbs to isolated ghosts, but not to intact red cells
(Landsberger et al., 1972).

2.7

EPR Measurements and Data Analysis
All EPR measurements were performed using a Varian E-Line Century Series EPR

spectrometer equipped with Varian E-102 microwave bridge, Varian V- 7700 power supply,
and IBM variable temperature control unit.

A scientific program, ASYST (MacMillan

Software), modified for EPR operation, was used for data acquisition and data analysis on a
Zenith personal computer. Typical settings for EPR measurements were: field set, 3252.5
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gauss; scan range, 100 gauss; field modulation, 100 kHz; modulation amplitude, 1 gauss; time
constant, 0.128 sec; receiver gain, 1.25 x 104 ; scan time, 30 sec (a slower scan time was used
initially. A shorter scan time was used to save time. No signal distortion was observed at this
scan time.); incident microwave power, 5 mW; and microwave frequency, 8.95 GHz.
The spin-labeled samples were kept at 4 °C, and EPR measurements at 37 °C were
carried out as soon as possible after the samples were made. The EPR cavity with a standard
quartz EPR tube filled half height of silicon fluid was pre-warmed to 37 ± 0.5 °C. About 2
min after the cold sample was placed in the quartz EPR tube, the sample temperature reached
37 °C, as indicated by a copper-constantan thermocouple inserted in the sample, in about 2
min. The EPR signals of the sample were recorded as a function of time for about 2 hr at 3 7
°C, with spectra taken about every 20 to 30 min.

During the time before the next

measurement, the sample was placed in a test tube which contained silicon oil and immersed
in a water bath at 37 °C. Some EPR measurements covered a period as long as 22 or 24 hr.
For a few samples, the central peak signal was monitored continuously with the following
procedures. First, an EPR spectrum was obtained, then the spectrometer was switched to the
non-scanning mode to continuously follow the peak height of the central peak. At a later
time, the spectrometer was switched to the scanning mode to obtain a full EPR spectrum.
Then the spectrometer was returned to the non-scanning mode to monitor the central peak.
Since the full EPR spectrum was obtained in about 2 min, no noticeable interruption was
detected for the continuous recording of the central peak height (Figure 1). The full EPR
spectra obtained in this manner allowed us to check the line-shape and line-width of the EPR
signals during the time period of the EPR experiments.

This approach provided more

accurate measurements of signal reduction, but more laborious and time consuming than the
one with spectra taken at different time intervals.
From the EPR spectra, the values of the central peak height at time t (ht, see Figure I)
were obtained. Since the EPR spectra had equivalent line-shapes and line-widths at different
times, the ht values were proportional to the spin concentrations at time t.
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Figure 1

A typical set of EPR signal reduction data for intact RBC spin labeled with
5-DSA spin label. At time 0 (left-hand side of the figure), the full spectrum
of the spin label was recorded with a central peak height of h 0 . Then the
central peak height was followed over a period of 2 hr (as shown on the top
of the figure). The tracing of peak height was interrupted occasionally during
the 2 hr time period to obtain full EPR spectra to check the line-shape and
line-width of the signals. EPR spectrometer settings for the full EPR spectra
were: field set, 3252.5 gauss; scan range, 100 gauss; field modulation, 100
kHz; modulation amplitude, 1 gauss; time constant, 0.128 sec; receiver gain,
1.25 x 104; scan time, 2 min; incident microwave power, 5 mW; and
microwave frequency, 8.95 GHz.

The central peak height at time t was

designated as ht. The EPR experiment was done at 37 °C.
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Double integration of the EPR spectra at different times verified that the spin
concentrations were directly proportion to the peak height values.
Pseudo first-order rate constants for spin label reduction reactions were obtained from
the slope of a linear regression fit of In (ht/h 0 ) vs time plot, where h 0 was the initial peak
height of EPR spectrum obtained at t

=

0 (see Figure I).

A SYSTAT (SYSTAT, Inc.)

statistical program for personal computer was utilized for the linear regression analysis.

2.8

Chemically Treated Samples

2.8.l

NEM-Treated Blood Sample
N-ethylmaleimide (NEM) was quantitatively weighed and dissolved in high phosphate

concentration buffers (155 mM NaH 2 P04 and 103 mM Na 2 HP0 4 , pH 8.0) to give several stock
solutions with concentrations varied from 1.67 to 125 mM. When lower concentrations were
desired, the NEM solution at 1.67 mM was used for further dilution. All NEM solutions were
made fresh. About I ml of washed RBC were mixed with 1.5 ml of NEM solution, at various
concentrations, to give final concentrations of NEM ranging from 0.01 to 75 mM. The
mixture was allow to stand for 10 min at 4 °C and then washed three more times with PBS.
A control sample in high phosphate concentration buffer was prepared at the same time. The
supernatant from each washing was optically checked against the characteristic absorbance
of NEM at 300 nm. After the third washing, no more NEM was left outside of the cells.
NEM-treated and control samples were spin labeled for EPR measurement as described in
sections 2.3 and 2. 7.

2.8.2

Mb* + Lysate + Antioxidant(s)
The antioxidants selected in this study were enzymes, such as SOD, CAT, GPx, as well

as membrane-associated vitamin E, and intracellular biomolecules, such as GSH, NADPH,
NADH, and ascorbate. All stock solutions were prepared in relatively high concentrations
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based on the dilution factors and the expected final concentrations after adding to Mb* and
lysate.

For an example, NADPH was dissolved in CO-gassed PBS buffer to give a

concentration of 2.88 mM. About 15 µ1, 7.5 µ1, and 5 µ1 of NADPH solution were mixed with
30 µ1 lysate and 15 µl of Mb* with additional 0 µ1, 7.5 µland 10 µl of CO-gassed PBS
correspondingly. The final NADPH concentrations in the samples were about 0.74, 0.38, and
0.26 mM, assuming that the lysate contained about 0.02 mM NADPH (Eaton et al., 1972).
The control sample consisted of 15 µl of CO-gassed PBS instead of NADPH solution. Another
set of control samples which consisted of Mb* and NADPH at concentrations equivalent to
those stated above, but excluded lysate was also prepared. Similarly, other antioxidants were
used either individually or in various combinations with two more antioxidants.
Since GSH and ascorbate solutions at concentrations higher than 5 mM were highly
acidic in PBS, they were freshly prepared with CO-gassed, high phosphate concentration
buffers to maintain the pH value at about 8.0. Vitamin E (d-a-tocopherol) was dissolved in
absolute ethyl alcohol, dried to a thin film with nitrogen gas, and suspended in CO-gassed
PBS by swirling with glass beads followed by sonication for about 10 min immediately before
use. The droplet of vitamin E was assumed to suspend homogeneously in the sonicated
solution.

2.8.3

Addition of Ascorbate Oxidase
Ascorbate oxidase (AO) with 100 units (1 unit oxidizes 1.0 µmole of L-ascorbate to

dehydroascorbate per min at pH 5.6 at 25 °C) was dissolved by addition of CO-gassed PBS
buffer, at various volumes to give AO solutions of different concentrations. About 5 µ1 of
AO solution were added to 40 µl of lysate, then mixed with 15 µ1 Mb*. A control sample was
made of 5 µl CO-gassed PBS, 40 µl lysate, and 15 µ1 Mb*.

2.9

Blood Samples for Antioxidant Assays
The same blood samples used for spin labeling were diluted with PBS buffer to give
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3o _ 50 % hematocrit. A large portion of the blood suspensions was immediately used or
stored at -20 °C for a period of no more than two months before subsequent vitamin E and
ascorbate determinations. Another portion was hemolyzed by adding a four-fold dilution of
deionized water and freeze (with an acetone/dry ice mixture) - thaw (with a water bath at
room temperature) 3 times. It was not necessary to remove the cell membrane in the sample.
One part of the lysate used for GPx assay was further diluted with an equal volume of GSH
diluent containing 2 mM GSH and 50 mM potassium phosphate buffer (pH 7.0) to avoid
losing GPx activity (Blanchflower et al., 1986), and the left-over lysate were then stored at
4 °c for the enzyme assays within 36 hr or kept in a freezer (-20 °C) for longer periods.
Before blood suspensions were lysed or the samples were stored in the freezer
(-20 °C), the number of cells in the samples was determined by means of CBC5 Coulter
Counter.

2.10

Antioxidant Assays

2.10.l Glutathione
The enzymatic method based on the reaction of formaldehyde (HCHO),
HCHO + NAD+ + H 2 0

----+

HCOOH + NADH + H+,

catalyzed by formaldehyde dehydrogenase in the presence of GSH (Koivusalo & U otila, 197 4 ),
was used for GSH assay with slight modifications. A volume of 1.0 ml blood sample (control
or NEM-treated) and 6 ml 10 % (w/v) metaphosphoric acid were mixed and filled up to a
total volume of 10 ml with deionized water, then centrifuged at 16,000 rpm (30,590 g) for 10
min. The supernatant was neutralized to pH 8.0 by adding 1 N NaOH with vigorous mixing.
Then the following solutions were transferred via pipettes into a test tube containing 240 µl
of above supernatant: 75 µl of 0.04 M NAD, 50 µl formaldehyde dehydrogenase solution
(minimum activity 500 mU/ml), and 2.4867 ml of 33 mM sodium phosphate buffer (pH 8.0).
The solutions were mixed well on a rotator and the reaction was initiated by the addition of
48.3 µl of 0.06 M HCHO. The tube was stopped and incubated at 37 °C for 30 min. The
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reaction was terminated by adding 100 µl of 0.10 M cysteine in deionized water. Then the
absorbance of the reaction mixture at 340 nm was read against a blank. The blank contained
all the assay mixture except deionized water was used instead of HCOH. A standard assay (5
_ 30 µM) were run in parallel with the sample assay.

2.10.2 Catalase
CAT was assayed by direct measurement of the decrease in absorbance at 240 nm as
H 2 0 2 was decomposed by CAT (Claiborne, 1985).
The lysate prepared, as described in the section 2.9, was further diluted by adding 50
µl of lysate to 10 ml deionized water. Hb concentration was estimated spectrophotometrically

using the millimolar extinction coefficient

E569 =

13.4/heme for CO condition and

E577 =

14.6/heme for 0 2 condition (Antonini & Brunori, 1971 ). A volume of 1.0 ml diluted lysate
was taken and mixed with 20 µl of pure ethanol for assay. A 10 mM H 2 0 2 solution was
prepared by adding stock H 2 0 2 solution into 50 mM potassium phosphate buffer (pH 7.0).
The final concentration was confirmed by measuring the absorbance at 240 nm and calculating
the concentration from the molar extinction coefficient of 43.6 M- 1cm- 1 .

The

spectrophotometer baseline was set with a blank containing 930 µl of 50 ml potassium
phosphate buffer (pH 7 .0) and 70 µl of lysate-ethanol mixture in a 1 ml quartz cuvette. The
absorbance at 240 nm for the solution containing 30 µl of 50 ml potassium phosphate buffer
(pH 7.0), 70 µl of lysate-ethanol mixture, and 900 µl of 10 mM H 20 2 was measured
immediately.
The specific activity of CAT was defined in terms of micromoles of H 2 0 2 consumed
per min per gram of Hb.

2.10.3 Superoxide Dismutase
The activity of SOD activity was assayed using the cytochrome C and xanthinexanthine oxidase method (McCord & Fridovich, 1969). In this assay, SOD competes with
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cytochrome C for the flux of 0 2 - induced by the xanthine and xanthine oxidase reaction. A
cocktail containing 50 mM potassium phosphate buffer (pH 7.8) with 0.1 mM EDT A, 50 µM
xanthine, and 10 µM cytochrome C was first prepared. The standard assay was performed in
a 3 ml cuvette with 2.7 ml cocktail, 0.3 ml deionized water, and about 1 µl xanthine oxidase
to produce a rate of cytochrome C reduction of 0.025 absorbance unit per min at 550 nm.
The SOD was extracted from the lysate, which was prepared with the method
described in section 2.9. 0.3 ml of lysate was added to 0.5 ml of ice-cold deionized water,
followed by adding 1.0 ml of pure ethanol and 0.6 ml of chloroform. Solutions were mixed
after each addition, and finally shaken for at least 1 min. The mixture was centrifuged at
3,000 rpm (1,075 g) for 10 min. SOD was found in the clear top layer, which was collected
for assay. 0.3 ml of extract instead of water was used under the same conditions as for the
standard assay.
One unit of SOD was defined as the amount of enzyme required to inhibit the initial
rate of cytochrome C reduction by 50 %. Results were expressed as units of SOD per gram
of Hb.

2.10.4 Glutathione Peroxidase
Indirect spectrophotometric methods of Paglia and Valentine (1967) and modified by
Blanchflower et al. (1986) were used for GPx determination. The GSH oxidation by H 20 2 as
catalyzed by GPx was coupled with the addition of glutathione reductase and NADPH. The
rate of oxidized glutathione (GSSG) formation was then measured by following the decrease
in absorbance of the reaction mixture at 340 nm as NADPH was converted to NADP.
The frozen lysate in GSH diluent, as described in section 2.9, was thawed and allowed
to stand at room temperature for 10 min before analysis. The following solutions were premixed as reagent mixture: 13.15 ml of 50 mM potassium phosphate buffer (pH 7.0) containing
5 mM EDTA, 0.5 ml of 8.4 mM NADPH, 0.5 ml of 0.15 M GSH, 50 µl of 1.125 M NaN 3 , and
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50 µ1of120 U/ml glutathione reductase suspension as purchased. About 0.95 ml of reagent
mixture and 16.7 µ1 lysate were transferred via pipettes into a 1 ml quartz cuvette. The
enzymatic reaction was initiated by addition of 33.3 µ1 2.2 mM H 2 0 2 , the concentration of
which was assured by checking its characteristic absorbance at 240 nm against its molar
extinction coefficient of 43.6 M- 1cm- 1 . The reaction rate was monitored by continuous
recording of the absorbance at 340 nm between 2 and 4 min after the initiation of the
reaction. The non-enzymatic oxidation of GSH was determined by simultaneous assay of a
system identical to the enzymatic reaction, except that the lysate was replaced by an equal
volume of water. The reaction rate of the latter system was subtracted from that of the
former to determine the true enzymatic activity.
Enzyme units for GPx activity were defined as the number of micromoles of NADPH
oxidized per min per gram of Hb, and were calculated by using a molar extinction coefficient
of 6.22 x 103 for NADPH.

2.10.5 Vitamin E
A standard fluorometric O!-tocopherol analysis was use to measure the vitamin E
concentration, following a modified method (Chiu & Lubin, 1979) of Taylor et al. (1976).
A mixture containing 2.0 ml PBS (pH 8.0), 0.5 ml of 25 % ascorbic acid (freshly
prepared), 1.0 ml pure ethanol, and 0.5 ml blood sample (30 % - 50 % hematocrit) was preincubated at 70 °C for 5 min in a 15 ml test tube with a cover. Following the addition of 1.0
ml of 10 N KOH, the mixture was saponified for 30 min at 70 °C. After the mixture had
been cooled down, 4.0 ml of hexane were added, and the saponified mixture was extracted
by mixing vigorously for at least 1 min on a vortex. The extracted mixture was centrifuged
at 3,000 rpm (1,075 g) for 5 min to separate the phases. A portion of the hexane phase (top
layer) was removed for fluorometric measurements at 290 nm excitation and 330 nm emission
on a Hitachi F-2000 fluorescence spectrophotometer. For all blanks and standards, water was
substituted for the blood sample.

Vitamin E standards were prepared by dissolving
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a-tocopherol in pure ethanol to give concentrations of 0.95 - 3.8 µg/ml. The concentration
of vitamin E in RBC was obtained from direct comparison of the sample fluorescence
intensity with that of the standards after correction had been made for the fluorescence
intensity of the blank, and was expressed as micrograms of a-tocopherol per gram of Hb.

2.10.6 Ascorbate
The ascorbate concentration was determined by an a,a'-dipyridyl method (Omaye et
al., 1979; Okamura, 1980). The assay was based upon the reduction of ferric ion by ascorbate

to ferrous ion, which was coupled with a,a'-dipyridyl to form a complex with a characteristic
absorption at 525 nm.
A modified method for extracting and measuring ascorbate of RBC was established
based on the methods of Omaye et al. (1979) and Okamura (1980). To 0.5 ml of CO-gassed
blood sample (either frozen-thawed lysate with Hb concentration about 150 mg/ml or RBC
suspension with hematocrit about 50 %) in a small centrifuge tube, 2.0 ml of 5 %
trichloroacetic acid (TCA) was added with vigorous mixing on a vortex for at least 2 min.
The mixture was centrifuged at 11,000 rpm (14,470 g) for 20 min at 4 °C. The following
reagents were added in sequence to 1.0 ml of the supernatant: 0.4 ml of 42.5 % H 3P0 4 , 0.4 ml
of 2 % a,a'-dipyridyl dissolved in 70 % ethanol, and 0.2 ml of 1.5 % FeC1 3 . The samples were
mixed vigorously upon addition of FeC1 3 and incubated at 37 °C for 60 min with covers.
Then absorbance readings against water at 525 nm were taken. Blank tests were carried out
at the same time as samples. Standard solutions of ascorbate, in a range of 0.5 - 10 µg/ml,
were prepared in 5 % TCA.

2.11

Statistical Analysis
Data were of ten analyzed statistically by using a two-sample t test and a paired-sample

t test. The two-sample t test is applied for comparison of two means of measurements from
two independent samples, assuming that each datum in one sample is in no way associated
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with any datum in the other sample. The paired-sample t test does not use the original
measurements for the two samples.

Instead, the differences between the pairs of

measurements are used, assuming that the differences come from a normally distributed
population of differences (Zar, 1974). The variability of the data is presented as an average
(Avg) with standard deviation (SD), or coefficient of variability (CV), which is defined as the
standard deviation divided by the average. Differences at p < 0.05 are usually considered
significant in biological systems (Zar, 1974).

CHAPTER III

RESULTS

3.1

Spin Label Reduction in Normal RBC

3.1.l

Spin Label Reduction by Intracellular Components
In this study, EPR signals were monitored as a function of time at 37 °C. A typical

set of EPR spectra showing signal reduction of 5-DSA in intact RBC over a period of 2 hr,
is illustrated in Figure 1. It shows that there is no change in the EPR signal line-shape or
line-width among the three full EPR spectra of the same sample obtained at different time
intervals during the reduction experiment. Therefore, the amplitudes of the central peak
could be used to measure the spin label signal reduction. Figure 2a is a plot of a typical set
of data for percent EPR signal reduction [(h 0

-

ht)/ h 0 x 100 %]. At the end of a period of

22 hr, a majority of the original signal of 5-DSA spin labels intercalated in the membranes
of CO-gassed intact RBC diminished, with only about 5 % signal retained. In contrast, EPR
signals persisted for the same spin labels intercalated in white membrane ghosts, which were
isolated from the same batch of erythrocytes, under the same experimental conditions as used
for intact erythrocytes. No signal reduction was observed, within± 5 %, over a period of 22
hr (Figure 2b). When about 40 µl of lysate, prepared from the same batch of blood sample
used for intact cell studies, was added to the Mb* (about 20 µl at about 8 mg/ml
concentration), a similar signal reduction profile (Figure 3c) was observed as in intact cells
(Figure 3b) over a period of 2 hr. These data suggest that intracellular components, which
were not present in the white membrane ghost sample (Figure 3d), were responsible for the
spin label signal reductions observed in intact cells.
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Figure 2

Percent EPR signal reduction [(h 0

-

ht)/ h 0 x 100 %] of 5-DSA spin label in

intact RBC and in white membrane ghosts over a period of 22 hr. Spinlabeled intact cells ( • , line a), spin-labeled white membrane ghosts ( •,
line b). The same batch of blood was used to prepare the samples.
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Figure 3

Similarity of signal reduction between spin-labeled membrane ghosts plus
lysate or spin-labeled intact RBC plus lysate and spin-labeled intact RBC.
Percent EPR signal reduction over a period of 2 hr for spin-labeled intact
cells plus lysate ((),line a), spin-labeled intact cells ( 0, line b), spin-labeled
membrane plus lysate ( .6, line c), and spin-labeled white membrane ghosts
( •. lined). Same batch of blood was used to prepare the samples.
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3.1.2

Reduction Rate Constants
In order to obtain rate constants from the signal reduction data presented above, it is

necessary to demonstrate that the spin label translocation rate is relatively faster than the spin
label reduction rate in the erythrocytes. When fatty acid spin labels were initially introduced
into the erythrocyte membranes, they resided in the outer leaflet of the membrane bilayer.
In order for them to be reduced by intracellular components, the labels must translocate to the

inner leaflet. A system which consisted of spin-labeled intact cells plus lysate was used to
examine such a hypothesis. If the translocation movements of the spin labels in membranes
were slow relative to EPR measurement time, some labels would locate in the outer leaflet
during the EPR experiments. Thus, one would expect that the addition of lysate to the intact
cells would result in faster reductions, since with lysate added both sides of the bilayer were
in contact with the reducing agents (intracellular components). Figures 3a and 3b show that
the spin label reduction obtained from the spin-labeled intact cells plus lysate is similar to that
from the intact cells. It is, therefore, concluded that the translocation movements of 5-DSA
spin labels in erythrocyte membranes are relatively faster than the spin reduction, and the
signal reduction data can be used to provide reduction rate constants.
The 5-DSA spin label reduction in many biological systems follows a first-order
reaction mechanism (Baldassare et al., 1974; Chen et al., 1988).

In our systems, initial

reduction rates (over a period of 2 hr) appeared to follow a first-order reaction mechanism,
exhibiting a linear fit in a semi-logarithmic plot with correlation coefficients generally> 0.99.
A semi-logarithmic plot of the data for the CO-gassed intact RBC is illustrated in Figure 4.
Since the spin label translocation rate is relatively faster than the spin reduction rate, the
linear fit for signal reduction data exhibited in Figure 4 represents a pseudo first-order spin
label reduction with a rate constant (k) of about 5.1 x 10-3 /min and the correlation coefficient
of 0.996 for the linear fit.
As discussed below, the k values varied from batch to batch (each batch was defined
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Figure 4

A semi-logarithmic plot of the fraction of initial signal (ht/h 0 x 100) versus
time for CO-gassed, spin-labeled intact cells. Raw data were from Figure I.
A linear fit gave a pseudo first-order rate constant for reduction of about
5.1 x 10-3 /min, with correlation coefficient of 0.996.

32

100
90

-=
.....
-..........

80

c:s

bf)

Cl'.l

-=
c:s

""""'
~
0

.....0=

70

60

C.)

•

c:s
.....

"1-1

50

\

40
0

50

100
Time (min)

150

33
as the blood sample from one blood bag obtained from a blood bank) of blood samples.

3.1.3

Experimental Uncertainties
To check the reliability and the reproducibility of the EPR measurements, reduction

rate constants were compared among the following groups of experiments: (I) multiple EPR
samples were prepared from the same spin-labeled samples, and stored at 4 °C until the EPR
measurements; (2) multiple spin-labeled samples were prepared from the same batch of blood;
(3) samples from the same batch of blood were prepared and measured on different days.
Table 1 shows that the k values were about the same within one batch of blood regardless of
groups. Data obtained from 18 batches of blood show that the values of CV of reduction rate
constants ranged from 1.3 % to 20.0 % (Table 1), with an average CV of about 9.5 ± 5.8 % for
individual batches of blood. This indicates that the experimental uncertainty of the rate
constants is about 10 %.

3.1.4

Variation of Blood Samples
Different batches of blood samples were used throughout this dissertation study. It

was found that the spin label reduction rates vary from batch to batch of blood. The k values
of 64 batches of normal blood samples ranged from 1.2 x 10-3 /min to 8.4 x 10- 3 /min, with
an average value of 3.8 ± 1. 7 x 10- 3/min. The CV for batch to batch was 44. 7 %.

3.1.5

Sample Characterization

3.1.5.l Amount of Spin Label
At the end of 24 hr, only about 5 - 20 % of the signal remained. In principle, the
higher the initial concentration of spin label in the erythrocyte membranes, the more
accurately one can follow the decrease in signal intensities of the spin label at different times.
However, spin-spin broadening poses an upper limit to the spin label concentration per cell
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Reduction Rate Constants from 18 Batches of Blood and the Variation
of Rate Constants within the Same Batch of Blood.

Table 1

Blood a

kc
(10- 3 /min)

Average k
(10- 3 /min)

CV

a
b

4.60
4.69

4.65 ± 0.06d

1.3

a
b
c

6.99
6.81
7 .11

6.97 ± 0.15

2.2

a
b

8.23
7.92

8.08 ± 0.22

2.7

a
b
c

1.64
1.73
1.71

1.69 ± 0.05

3.0

a
b

1.28
1.18

1.23 ± 0.07

5.7

a
b

4.21
4.61

4.41 ± 0.28

6.3

a
b
c

3.39
3.22
2.98

3.20 ± 0.21

6.6

a
b

3.35
2.99

3.17 ± 0.25

7.9

a
b

2.85
3.23

3.04 ± 0.27

8.9

a
b

2.85
3.23

3.04 ± 0.27

8.9

a
b

6.13
7.00

6.57 ± 0.61

9.3

Sam pleb

1
2

3
4

5
6
7

8
9
10
11

(%)

aEach entry under Blood represents one batch of blood from the blood bank.
bEach entry under Sample represents an EPR sample.
ck is the pseudo first-order rate constant for spin label reduction.
dstandard deviation.
(continued)
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Table 1

(continued)

Blood a

Sampleb

12

13
14
15

16

17

18

kc
(10- 3 /min)

Average k
(10- 3 /min)

CV

a
b
c

7.91
6.42
7.05

7.13 ± 0.75d

10.5

a
b

2.08
1.79

1.94 ± 0.21

10.8

a
b

3.46
2.83

3.15 ± 0.45

14.3

a
b
c

4.46
3.44
3.35

3.75 ± 0.62

16.5

a
b
c
d
e
f

3.73
2.98
3.97
3.34
4.21
4.85

3.85 ± 0.66

17 .1

a
b
c

3.35
4.21
4.93

4.16 ± 0.79

19.0

a
b

5.20
6.91

6.06 ± 1.21

20.0

(%)

The average coefficient of variability (CV) of k for multiple samples prepared
from the same batch of blood is 9.5 ± 5.8 %.
aEach entry under Blood represents one batch of blood from the blood bank.
bEach entry under Sample represents an EPR sample.
ck is the pseudo first-order rate constant for spin label reduction.
dStandard deviation.
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that can be used for this study. The spin labels may cluster at higher concentrations to distort
the EPR signal. In studies when fatty acid spin labels were introduced directly into red blood
cell membrane ghosts, the spin labels clustered in membranes at a spin label-to-lipid ratio of
about 1/360, resulting in spin-spin exchange induced broadening in the EPR spectra (Gordon

et al., 1985). In our study, the spin label concentrations in cell membrane varied from 5.8 x
10-5 M to 2.4 x 10- 4 M as measured at t

=

0. The line-widths of the EPR signals were

carefully checked, and no spin broadening was observed in the EPR spectra. In addition, the
reduction rate constants were not affected by the different initial spin label concentrations,
which is in agreement with the first-order reaction kinetics.

3.1.5.2 Labeling Time
Usually, labeling RBC with BSA* or Mb with free spin label in PBS was allowed for
30 min at 4 °C before washing away the excess spin label solution. However, we found that
a labeling time of 10 min was sufficient. Under this condition (10 min labeling), the EPR
intensity of spin label signal at t = 0 was 1.4 x 10-4 M (7 .8 x 10 6 spin labels per cell), similar
to 1.7 x 10-4 M (9.0 x 10 6 spin labels per cell) when 30 min of labeling time was used. The
spin label reductions of CO-gassed intact cells with different labeling times were about the
same (Figure 5).

3.1.5.3 Microwave Power
To increase the intensity of EPR signal at one spin label concentration, one can
increase the incident microwave power. However, when the microwave power is too high the
spin label resonance may be saturated. It has been suggested that a power level of 1 - IO mW
for nitroxide spin label is appropriate to avoid saturation (Marsh, 1981 ). In this study, 1 mW
of microwave power was used for the earlier experiments and 5 mW of microwave power was
used for most of the later experiments.
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Figure 5

Spin label reduction of intact RBC with different labeling times. A semilogarithmic plot of the fraction of initial signal versus time for spin-labeled
intact RBC with labeling time 10 min ( £)and 30 min ( • ). The reduction
rate constant obtained from the linear fit is 3.3 x I 0- 3 /min for I 0 min labeling
time, with a correlation coefficient of 0.994, and 3.0 x 10-3 /min for 30 min
labeling time, with a correlation coefficient of 0.994.
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To check whether different levels of microwave power affect the spin label reduction,
multiple EPR samples were made from the same spin-labeled sample. EPR spectra were
obtained using 1 mW and 5 mW microwave power, with other spectrometer settings held
constant. Table 2 lists the reduction rate constants from four parallel runs of CO-gassed RBC
using different power levels. A paired-sample t test was applied to show that the differences
in rate constants from the samples using 1 mW and 5 mW microwave power were not
significant (p > 0.50).

3.1.6

Effects of Sample Conditions

3.1.6.1 Anticoagulants
Since different anticoagulants (heparin, EDTA, etc.) were used for some of the normal
and sickle RBC, the effect of anticoagulants on the spin label reduction rates should be
considered. To examine the possible effect, blood samples from the same donors or patients
were drawn into heparin coated tubes and EDT A coated tubes at the same time. The blood
samples were retained in the tubes for at least 2 hr at 4 °C. Then, the cell washing and spin
labeling procedures were followed. Sequentially, spin label reduction was measured, and the
reduction rates constants were obtained (Figure 6). For one RBC sample (from a normal
donor), the reduction rate constant was 3.4 x 10-3 /min when EDTA was used as an
anticoagulant, and was 3.0 x 10- 3 /min when heparin was used as an anticoagulant. For
another sample (from a sickle patient), the rates were 11.5 x 10-3 /min and 11.7 x 10- 3/min
for EDT A and heparin as anticoagulants, respectively.

Thus, the results show that

anticoagulants have no significant effect on the spin label reduction for both normal and
sickle RBC.
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Table 2

Spin Label Reduction Rate Constants from Four Parallel Runs of CO-gassed
Normal RBC at Two Different Microwave Power Levels

Run

1 mW

5mW

diff.

4.30

3.46

0.84

2

3.73

3.97

-0.24

3

2.94

3.34

-0.40

4

4.86

4.21

0.65

paired-sample t test, t

=

0.682, p > 0.50.
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Figure 6

Spin label reduction of both normal and sickle RBC with different
anticoagulants. A semi-logarithmic plot of the fraction of initial signal versus
time for the blood samples from normal donor ( • ) and sickle patient (

+)

with anticoagulant EDTA (closed symbols) or heparin (opened symbols). For
the blood sample from normal donor, the reduction rate constant is 3.4 x
10- 3 /min for EDTA used as anticoagulant, with a correlation coefficient of
0.998, and 3.0 x 10-3 /min for heparin used as anticoagulant, with a correlation
coefficient of 0.996. For the sample from sickle patient, the rate constant is
11.5 x 10-3 /min for EDT A used as anticoagulant, with a correlation
coefficient of 0.990, and 11.7 x 10-3 /min for heparin used as anticoagulant,
with a correlation coefficient of 0.990.
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3.1.6.2 CO-Gassed and OrGassed RBC
It was found that for the same batch of blood cells the spin label reductions for 0 2 gassed samples were lower than those for CO-gassed samples. This is in part due to reoxidation of the spin label from hydroxylamine form (EPR silent) back to nitroxide form
(EPR active) (Chen & Swartz, 1989) by 0 2 molecules in the system. Figure 7 shows a semilogarithmic plot of data obtained from typical CO- and 0 2 -gassed samples. The EPR signal
reduction data of the CO-gassed sample followed a linear fit with a correlation coefficient of
1.000. However, the data for the 0 2 -gassed sample did not give a good linear fit when data
points beyond 90 min were included, since the reduction rate began to decrease. If we do not
include the data points beyond 90 min, where the reaction could no longer be described by
pseudo first-order kinetics, the data followed a relatively good linear fit, with a correlation
coefficient of 0.996. From this analysis, a rate constant of 6.4 x 10-3 /min was obtained for
the CO-gassed sample, and 3.0 x 10- 3 /min for Or gassed sample. The average ratio of
k(CO)/k(0 2 ) was 2.3 ± 0.9 for 15 different paired experimental runs.
It is, therefore, important to have erythrocytes fully CO-gassed, as indicated by the
conversion of Hb0 2 to HbCO in intact spin labeled erythrocytes. Otherwise, the extent of the
spin label reduction in cells will be affected by the amount of oxygen molecules in the system.

3.2

Effects of RBC Components that Reduce Membrane Spin Labels

3.2.1

Components with No Effects

3.2.1.1 Vitamin E
Vitamin E is a membrane-associated, lipophilic antioxidant. Its spin label reduction
capacity in Mb* was examined with and without lysate. The rate constant for the membrane
with lysate was 1.1 x 10- 3 /min (Figure 8b).

Upon addition of vitamin E, at a final

concentration about 11.8 mM, the rate constant was 1.3 x 10-3 /min (Figure 8c), very similar
to that without the addition of vitamin E.

44

Figure 7

A semi-logarithmic plot of the fraction of initial signal versus time for spin

label in intact red blood cells with the red blood cells in CO and 0 2 gassed
buffer. The linear fit gives a reduction rate constant of 6.4 x 10- 3 /min for
CO gassed samples ( •) with a correlation coefficient of 1.000, and 3.0 x
10-3 /min for 0 2 gassed samples ( .A ) during the first 90 min, with a
correlation coefficient of 0.996.
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Figure 8

Examination of vitamin E effect on spin-labeled membrane ghosts. A semilogarithmic plot of the fraction of initial signal versus time for spin-labeled
membrane ghosts with 11.8 mM vitamin E ( f.r, line a), lysate ( • , line b ), or
11.8 mM vitamin E and lysate (

*, line c). The rate constant obtained from

the linear fit is 0.02 x 10-3 /min for vitamin E in the absence of lysate, with
a correlation coefficient of 0.248. The rate constant for lysate sample is I. I
x I o- 3 /min, with a correlation coefficient of 0.996, and for vitamin E and
lysate is 1.3 x 10-3 /mim, with a correlation coefficient of 0.998.
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Samples containing only vitamin E and Mb* in the absence of lysate did not show any
detectable reduction (Figure 8a).

3.2.1.2 Glutathione
In order to study the involvement of GSH in the reduction process, two types of
experiments were performed by using (I) NEM-treated RBC to block GSH and (2) direct
addition of GSH to Mb* in the presence and absence of lysate.
For NEM-treated RBC, the concentrations of GSH in EPR samples were determined.
Figure 9 shows a plot of percentage of the remaining GSH concentration and relative spin
label reduction rate constant, defined as the rate constant from a treated sample divided by
the rate constant of its control, in normal RBC treated with various concentration of NEM.
About 1.0 mM of NEM was required to block about 90 % of GSH in intact RBC, but the
blockage did not affect the rate constants. Cells treated with more concentrated NEM (IO 75 mM) gave about same amount of residual GSH, in part due to the detection limit in GSH
assay. Nevertheless, the relative reduction rate constants retained the same as the untreated
sample (Figure 9).
In another experiment, GSH ( 4.0 mM) was added to Mb*, and the spin label reduction,

monitored over a period of 2 hr, was found to be negligible (Figure lOa). In the presence of
lysate, addition of 4.0 mM GSH to lysate which contained about 1.5 mM GSH, based on the
physiological value of 3.0 mM (Mehlhorn, 1991) and a dilution factor of the sample, to give
a final concentration of 5.5 mM did not significantly enhance the reduction.

The rate

constant was 1.6 x 10-3 /min (Figure lOc ), similar to 1.5 x 10-3 /min obtained from its control
(Figure lOb). The results from these experiments showed that GSH did not reduce 5-DSA
spin labels in membrane.
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Figure 9

Percentage of remaining GSH concentration and relative spin label reduction
rate constant in intact red blood cells treated with various concentrations of
NEM.
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Figure IO

Examination of GSH effect on the spin-labeled membrane ghost in the
absence and presence of lysate. A semi-logarithmic plot of the fraction of
initial signal versus time for spin-labeled membrane ghosts with 4.0 mM GSH
( t>, line a), lysate ( •, line b), or 4.0 mM GSH and lysate ( ... ,line c). The

rate constant obtained from the linear fit is -0.15 x 10- 3/min for GSH in the
absence of lysate, with a correlation coefficient of 0.854. The rate constant
for lysate sample is 1.5 x 10-3 /min, with a correlation coefficient of 0.989,
and for GSH and lysate is 1.6 x I 0- 3 /mim, with a correlation coefficient of
0.988.
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3.2.1.3 Antioxidant Enzymes
The major enzymes that scavenge reduced products of oxygen, such as SOD, catalase,
and GPx, were chosen to study the effects of individual antioxidant enzymes on the spin label
reduction by adding them to Mb* in the presence and absence of lysate. The concentrations,
Figure 9 legend in terms of activity unit per ml, of each enzyme used in the experiments were
at least twice as high as their physiological value. Figure 11 shows that addition of each
enzyme, at the highest concentrations used in this study (14,271, 83, and 6,667 units/ml for
CAT, GPx, and SOD, respectively), to the Mb* and lysate did not yield additional spin label
reduction as compared with control samples. The relative rate constants were 1.0, 1.1, and
0.9 for CAT, GPx, and SOD, respectively. In addition, samples containing Mb* with CAT,
GPx, or SOD did not show any observable spin label reduction, indicating these enzymes did
not reduce the nitroxide radicals in membrane.

3.2.1.4 Carbonmonoxy Hemoglobin
To determine whether HbCO is involved in the spin label reduction, purified normal
Hb in CO ligation was added into spin-labeled membrane in CO-gassed buffer at 4 °C and
the EPR signal was monitored at 37 °C. The data from Mb* with 4 different concentrations
of HbCO, varied from 70 mg/ml to 200 mg/ml, are displayed in Figure 12. Since the Mb
concentration of the samples was about 3 mg/ml, the weight ratio of HbCO/Mb varied from
23 to 67, it was wide enough to cover the physiological ratio of 28, as calculated from known
values (335 mg/ml of Hb and 11.8 mg/ml of Mb for packed RBC) (Surgenor, 1974). In all
cases, no significant reduction was observed, with fluctuation similar to that by Mb* alone.
Therefore, HbCO at concentration of up to 200 mg/ml does not affect spin label reduction
over a period of 2 hr.
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Figure 11

Reduction rate constant of spin-labeled membrane and lysate with excess
addition of antioxidant enzyme CAT, GPx, or SOD. Controls contained
spin-labeled membrane ghosts and lysate only. For each paired samples, the
same batch of blood sample was used. The concentration of enzyme added to
the sample was 14,271 unit/ml for CAT, 83 unit/ml for GPx, and 6,667
unit/ml for SOD.
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Figure 12

Examination of HbCO effect on the spin-labeled membrane ghosts. A semilogarithmic plot of the fraction of initial signal versus time for spin-labeled
membrane ghosts alone (

o ) and with

(A), 120 mg/ml ( • ), 150 mg/ml (

HbCO at concentrations of 70 mg/ml

* ), and 200 mg/ml ( +>.
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3.2.2

Components with Effects

3.2.2.1 Reduced Pyridine Nucleotides
Both NADH and NADPH are important reducing equivalents in reactions that are
critical in protecting cells against oxidant damage in RBC (Eaton & Brewer, 1974; Zerez et
al., 1988). The addition of NADPH or NADH into the lysate significantly increased the

reduction rate of Mb*. Figure 13 shows that when 720 µM of NADPH was added to the
lysate, the rate constant of Mb* with lysate for one batch of blood was increased from 1.2 x
10-3 /min to 2.6 x 10- 3 /min; and for another batch of blood, the rate constant of sample
without NADPH was 1.5 x 10-3 /min, and with NADPH was 3.4 x 10- 3 /min. In both cases,
the relative rate constants were about 2.2 upon addition of NADPH. The addition of NADH
to lysate, at about the same amount used as for NADPH, also enhanced the reduction rate
from 0. 7 x 10-3 /min to 1.2 x 10- 3 /min, with a relative rate constant of 1. 7. Both NADPH and
NADH enhancements were concentration dependent as shown in Figure 14. The apparent
second-order rate constant obtained from the slope of the plot for NADPH was 2.2/min·M
with a good linear fit (r

=

0.992). For NADH, the apparent second-order rate constant was

0.6 /min·M and the correlation coefficients for the linear regression was 0.943. It should be
pointed out that there was no EPR signal reduction for Mb* with NADPH or NADH in the
absence of lysate. These results indicate that reduced pyridine nucleotides functioned as
reducing agents only when they were cofactors for other reactions in the lysate.
The effects of combinations of enzymes and GSH with NADPH in Mb* plus lysate on
spin label reduction were then examined. Samples consisting of Mb*, lysate, NADPH, SOD,
CAT, GPx, GSH, and other combinations are illustrated in Table 3. The concentrations of
each antioxidant added to samples were close to or higher than physiological values. The
reduction rate constants from these samples were normalized to the rate constant from Mb*

+ lysate + NADPH.
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Figure 13

Enhancement of spin label reduction by NADPH in the presence of lysate.
A semi-logarithmic plot of the fraction of initial signal versus time for
samples containing spin-labeled membrane ghosts and lysate alone (.A ) and
with additional 720 µM NADPH (

* ).

The shaded symbols are from blood

sample one, and closed symbols are from blood sample two. The rate constant
obtained from linear fit for blood sample one is 1.2 x 10- 3 /min with a
correlation coefficient of 0.989,

while for the same blood sample with

additional NADPH is 2.6 x 10- 3 /min with a correlation coefficient of 0.994.
The rate constant for blood sample two is 1.5 x 10-3 /mim, with correlation
coefficient of 0.988, and for the same blood sample with additional NADPH
is 3.4 x 10-3 /min, with correlation coefficient of 0.999.
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Figure 14

NADPH and NADH concentration dependence of spin label reduction in the

presence of lysate.
NADPH (

Spin-labeled membrane and lysate with addition of

*)

or NADH ( • ). Different batches of blood were used for

NADPH and NADH experiments.
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Table 3

Effects of Enzymes and GSH with NADPH in Spin-Labeled Membrane
and Lysate on Spin Label Reduction

System

Relative Rate Constant

Mb* + Lysate + NADPH (720 µM)
(control)

1.0

control+ CAT (14271 unit/ml)

1.1

control + GPx (83 unit/ml)

0.9

control+ SOD (6667 unit/ml)

1.0

control+ GSH (4 mM)

I.I

control+ CAT (1247 unit/ml)+ GPx (18 unit/ml)
+ SOD (2000 unit/ml)

1.0

control+ CAT (1247 unit/ml)+ GPx (18 unit/ml)
+ GSH (2mM)

1.0

control + CAT (1247 unit/ml)
+ SOD (2000 unit/ml) + GSH (2mM)

1.0

control+ GPx (18 unit/ml)
+ SOD (2000 unit/ml) + GSH (2mM)

1.0

control+ CAT (1247 unit/ml)+ GPx (18 unit/ml)
+ SOD (2000 unit/ml) + GSH (2mM)

1.0

The concentration of each antioxidant is the amount of addtion, which does not
include the amount in lysate.
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The results showed that addition of enzymes and/or GSH gave about the same effects
(within± IO%) as NADPH alone in the Mb* with lysate. In the absence of lysate, Mb* and
NADPH combined with other components showed no detectable spin label reduction over a
time period of 2 hr. In Table 4 the relative signals remained of the tested samples with Mb*
+ NADPH as 100 % are listed.

3.2.2.2

Ascorbate

3.2.2.2.1

In Buffer System

Ascorbate is an aqueous antioxidant, and is known to reduce water-soluble nitroxides
in solution. It was found that 5-DSA spin label with 1.0 mM of ascorbate in PBS buffer
underwent a pseudo first-order reduction within the first 15 min with a rate constant of 31.0
x I 0- 3 /min and correlation coefficient of 0.996. Over a longer period of time the rate slowed
down and did not follow first-order kinetics.

3.2.2.2.2

In Membrane System

Ascorbate was added to Mb* and studied for its reducing ability in membrane systems.
It was found that ascorbate, at concentration of 1.0 mM, also reduced the spin label in

membrane, but the reduction rate was much slower than that in buffer. The pseudo firstorder rate constant was 2.5 ± 0.2 x 10-3 /min (n

=

3). The spin label reduction of Mb* by

ascorbate appeared to be concentration dependent. The reduction rate constant increased to
10.4 ± 1.2 x 10- 3 /min (n

=

3) at ascorbate concentration of 3.3 mM.

When ascorbate

concentration decreased to the physiological concentration of about 0.1 mM, there was no
detectable signal reduction. Plotted in Figure 15 are the pseudo first-order rate constants as
a function of ascorbate concentrations. An apparent second-order rate constant obtained from
the slope for Mb* + ascorbate was 3.1/min·M, with a correlation coefficient of 0.996.
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Table 4

Effects of NADPH with Other Components in Spin-Labeled Membrane
on Spin Label Reduction

System

Relative Signal Remaining(%)

Mb* + NADPH (720 µM)
(control)

100

control + Hb (125 mg/ml)

96.8

control+ GSH (40 mM)

99.5

control+ CAT (14271 unit/ml)

99.8

control+ GSH (40 mM) + GPx (300 unit/ml)

95.3

control + GSH (40 mM) + SOD (4000 unit/ml)

100

control+ Hb (125 mg/ml)+ GSH (4 mM)
+CAT (1247 unit/ml)+ GPx (18 unit/ml)
+ SOD (2000 unit/ml)

105
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Figure 15

Ascorbate concentration dependence of spin label reduction in the presence
or absence of lysate. Spin-labeled membrane with lysate and addition of
ascorbate ( A); spin-labeled membrane with ascorbate ( A ).

Error bars

represent the standard deviation of 2 or 3 measurements using different
batches of blood sample.
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No detectable spin label reduction was observed when 2 units/ml of AO, which
oxidizes ascorbate to DHA, was added to either the spin label in buffer or Mb* system that
contained 1.0 mM of ascorbate. Thus, the spin label reduction by ascorbate could be inhibited
by AO.
In addition, it was found that in the presence of 4.0 mM GSH the spin label
reduction rate constant of Mb* with 1 mM ascorbate increased from 2.5 x 10-3 /min to
6.2 ± 0.5 x 10-3 /min (n

=

2), while the same amount of GSH did not reduce spin label in

membrane, as stated in Section 3.2.1.2. At 2.5 mM of ascorbate, the rate constant increased
from 7.6 x 10-3 /min to 11.8 x 10-3 /min in the presence of 4.0 mM GSH. The apparent
second-order rate constant obtained from the two data points was 4.7 /min·M for Mb* with
ascorbate in the presence of 4.0 mM GSH.
Interestingly, the spin label reduction of Mb* caused by the mixture of 1 mM
ascorbate and 4.0 mM GSH was not inhibited by AO, even when AO concentration was
increased from 2 to 20 unit/ml. The rate constants were 5.5, 5.8, and 5.9 x io- 3 /min for 2,
7.6, and 20 units/ml of AO, respectively. As mentioned in the Methods section, the sequence
of adding reagents was random, except Mb* was always the last component to be added to the
solution. No significant effects on the rate constants were observed when reagents were added
in a different order.
To clarify whether GSH could inhibit AO for the oxidation of ascorbate, a parallel
experiment was conducted in a UV cuvette while monitoring the characteristic UV peak
absorbance range of ascorbate from 225 nm to 325 nm. It was found that the addition of GSH
did not significantly affect the UV absorbance spectra of ascorbate, and the peak steadily
decreased after AO was added in both cases when GSH was either present or not.

3.2.2.2.3

In Membrane with Lysate System

The ascorbate effect was studied for the spin label reduction of Mb* in the presence
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of lysate. Figure 16 presents a plot for relative rate constants of Mb* and lysate treated with
AO vs amount of AO added. The results showed that the spin label reduction rates were
reduced by about 80 % after treatment of lysate with less than 0.1 unit/ml of AO. At AO
concentration of about 1 unit/ml or larger, nearly no spin label reduction was detected with
the reduction rate constants fluctuating at a certain low level.
Figure l 7a shows the reduction of Mb* with lysate and 3.3 mM ascorbate as a function
of time in a typical run. An average rate constant for the membrane with lysate was 1.2 ± 0.4
x 10-3 /min (n

=

7). Addition of 3.3 mM ascorbate to lysate increased the reduction rate

constant to 26.7 ± 1.2 x 10- 3 /min (n = 3). These rate constants were determined over a period
of only 1 hr, because the signal reduction data of samples with ascorbate leveled off beyond
that period in a semi-logarithmic plot. It was found that in the presence of lysate ascorbate
could reduce spin label in membrane faster than that in the absence of lysate with the same
concentration of ascorbate added, as shown in Figure 15. For Mb* + lysate + ascorbate, a
linear ascorbate concentration dependence was also observed. An apparent second-order rate
constant obtained from the slope was 7 .6/min·M with a correlation coefficient of 0.997.
The enhanced reduction with rate constant of 3.0 x 10-3 /min at 0.2 mM ascorbate was
inhibited by addition of 2 units/ml AO and showed no detectable reduction.
The addition of 11.8 mM vitamin E to samples with 3 .3 mM ascorbate did not further
increase the reduction (Figure 17b). The rate constant was 26.4 ± 1.2 x 10-3 /min (n

=

3) as

determined over a period of 1 hr.
The combined effects of NADPH and ascorbate were also studied as follows: (I) to
study the inhibition effect of AO on the spin label reduction of Mb* with NADPH treated
lysate; (2) to measure the ascorbate concentration directly in NADPH treated lysate.
In the presence of 2 units/ml of AO, the reduction rate of Mb* and lysate with 720

µM NADPH was inhibited by only about 50 %, with rate constant reduced from 2.8 x
10- 3 /min to 1.4 x 10-3 /min.
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Figure 16

Inhibition of spin label reduction by AO in lysate. Relative rate constant

represents the ratio of rate constant of AO-treated lysate (ka0 ) to rate constant
of the lysate without AO treatment (k 0 ). Different batches of blood were used
to prepare the samples.
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A similar result was observed for lysate treated with 540 µM NADPH. The rate
constant reduced from 2.5 x 10-3 /min to 1.3 x 10- 3 /min in the presence of 0.8 units/ml AO.
The results from ascorbate concentration measurement are shown in Figure 18. For
one set of samples, lysate samples were mixed with buffer in the absence and presence of 720

µM NADPH and stored at 4 °C overnight. The concentrations of ascorbate were measured
the next day and found to be 13.35 and 2.09 µg/gHb for NADPH treated lysate and control,
respectively. For another set of samples, ascorbate concentration measurements were done
immediately after 720 µM NADPH was added to lysate. The ascorbate concentrations were
19.09 and 11.61 µg/gHb for NADPH treated lysate and control, respectively. Although the
sample conditions for these two sets of experiments were not exactly the same and the
uncertainty for ascorbate concentration measurement was not determined, the results from
both cases showed that the ascorbate levels of NADPH-treated lysate were increased when
compared with their controls.

3.2.2.3 Dehydroascorbate
The spin label reduction of Mb* by DHA was studied. It was noticed that a transient
delay for DHA to reduce spin label in Mb* existed in the concentration range (I - 2.5 mM)
studied (Figure 19). The reduction rate did not appear to fit the first-order kinetics as well
as the other systems studied. In order to compare with previous results, the pseudo first-order
rate constants were obtained, despite relatively low correlation coefficient values. The rate
constants were 0.5, 4,4, and 10.9 x 10-3 /min for 1.0, 1.5, and 2.5 mM of DHA added to Mb*
respectively. The apparent second-order rate constant was 4.5/min·M with a correlation
coefficient of 0.929.

Addition of 4.0 mM GSH to Mb* and DHA increased spin label

reduction with a rate constant of 3.6 x 10- 3/min at 1.0 mM DHA and 8.0 x 10-3 /min at 1.5
mM DHA.

The apparent second-order rate constant was 5.1/min-M with a correlation

coefficient of 0.968.
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Figure 18

Effect of NADPH treatment on ascorbate concentration in lysate. For the set
one, the lysate samples were mixed with buffer in the absence ( D ) and
presence (

II ) of 720

µM NADPH and stored at 4°C overnight.

Concentrations of ascorbate in the samples were measured the next day. For
the set two, ascorbate concentration measurements were done immediately
after 720 µM NADPH was added to the lysate.
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Figure 19

Percent EPR signal reduction over a period of 2 hr for spin-labeled
membrane with DHA at different concentrations. DHA concentrations are:
1.0 mM ( £ ), 1.5 mM (

+ ), and 2.5 mM ( * ).
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The spin label reduction caused by either DHA alone or the mixture of DHA and GSH
could not be inhibited by AO. The rate constants for DHA with 10 units/ml of AO were 2.0,
5.5, and 11. 7 x 10-3 /min for 1.0, 1.5, and 2.5 mM DHA respectively. The rate constants for
DHA with 4.0 mM GSH and 10 units/ml AO were 4.0 x 10-3 /min and 7.8 x 10- 3/min for 1.0
and 1.5 mM DHA.
The addition of 0.5 mM DHA to Mb* with lysate increased the rate constant from 1.1
x 10-3 /min to 4.1 x 10- 3 /min. Addition of 2 units/ml AO to this DHA, lysate and Mb*
system reduced the rate constant to 1.3 x 10-3 /min.

3.2.2.4 HbCO and Cell-02 Condition
As mentioned earlier, the cell condition could affect the reduction rate of spin label.
It was noticed that when cells were first washed three times with CO-gassed buffer to fully

saturate the Hb, then washed once with un-gassed or 0 2 -gassed buffer after spin labeling, the
HbCO form did not change to Hb0 2 as confirmed by optical measurement. However, the
reduction rate from this RBC sample was lower than the fully CO-gassed RBC sample and
higher than the fully 0 2 -gassed RBC sample. Figure 20 shows a percentage reduction plot
of data obtained from a parallel run of samples under three conditions. Samples were made
in duplicates for each condition. The rate constant was 6.9 ± 0.6 x 10-3 /min for the fully COgassed sample; 3.2 ± 0.3 x 10- 3/min for the fully Or gassed sample during the first 90 min,
and 4.3 ± 0.3 x 10- 3/min for the sample under the condition of HbCO and cell-0 2 •

3.2.3

Summary of the Effects of RBC Components on Spin Label Reduction
A summary of all the components examined for spin label reduction in membrane and

membrane with lysate is presented in Tables 5 and 6. The concentration of each component
listed was usually the highest concentration used for the study, especially for the components
with no effects on the spin label reduction.
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Figure 20

Percent EPR signal reduction over a period of 2 hr for samples in different
conditions.

Fully CO-gassed RBC samples ( •

), fully 0 2 -gassed RBC

samples ( "' ), and samples under the condition of HbCO and cell-0 2

( •

).

Samples were prepared from the same batch of blood and made duplicate for
each condition.
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Table 5

Summary of the Effects of RBC Components on Spin Label Reduction
in Membrane

Component

Cone. of the
Material Added

Rate Constant
(10- 3 /min)

Vit E
GSH
SOD
CAT
GPx
HbCO
NADH
NADPH

11.8 mM
4.0mM
6667 unit/ml
14271 unit/ml
83 unit/ml
200 mg/ml
720 µM
720 µM

ND
ND
ND
ND
ND
ND
ND
ND

Ascorbate

0.1 mM
1.0 mM
2.5mM
3.3mM

ND
2.5
7.6
10.4

Ascorbate
+AO

l.OmM
2 unit/ml

ND

Ascorbate
+GSH

l.OmM
4.0mM

6.2

2.5mM
4.0mM

11.8

Ascorbate
+ GSH
+AO

l.OmM
4.0mM
20 unit/ml

5.9

DHA

1.0 mM
1.5 mM
2.5 mM

0.5
4.4
10.9

DHA
+AO

2.5 mM
10 unit/ml

11.7

DHA
+ GSH

1.0 mM
4.0mM

3.6

1.5 mM
4.0mM

8.0

1.5 mM
4.0mM
10 unit/ml

7.8

Cone. Dependent
Rate Constant

--------------------------------------------------------------------------

DHA
+ GSH
+AO
ND

=

not detectable.

3.1/min-M

4.7/min·M

4.5/min·M

5.1/min·M

Table 6

Conponent

Summary of the Effects of RBC Components on Spin Label Reduction in Membrane with Lysate

Cone. of the
Material Added

Cone.
in Lysatea

Rate Constant
(10- 3/min)

Ratiob

1.2 ± 0.4

1.0

1.3

I. I

Cone. Dependent
Rate Constant

Vit E

11.8 mM

GSH

4.0 mM

1.5 mM

1.6

1.1

SOD

6667 unit/ml

500 unit/ml

1.1

0.9

CAT

14271 unit/ml

350 unit/ml

2.3

1.0

GPX

83 unit/ml

4.5 unit/ml

1.7

1.1

HbCO

NMC

NADH

720 µM

20 µM

1.2

1.7

0.6/min-M

NADPH

720 µM
540 µM

20 µM

2.9 ± 0.4
2.5

2.2
1.7

2.2/min·M

aestimated based on physiological values and a dilution factor of 2.
brate constant of sample relative to that of its own control.
cnot measured.
(continued)
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Table 6

(continued)

Conponent

Cone. of the
Material Added

Cone.
in Lysatea

Rate Constant
(10- 3 /min)

Ratiob

Ascorbate

0.2mM
3.3mM

<0.05 mM

3.0
26.7

2.8
22.3

Ascorbate
+AO

0.2 mM
2 unit/ml

NDd

AO

0.1 unit/ml
I unit/ml

0.3
NDd

0.2

NADPH
+AO

720 µM
2 unit/ml

1.4

0.5e

1.3

0.5e

4.l

3.7

1.3

0.3e

20 µM

540 µM
0.8 unit/ml
DHA

0.5 mM

DHA
+AO

0.5 mM
2 unit/ml

< 0.002 mM

Cone. Dependent
Rate Constant

7.6/min·M

aestimated based on physiological values and a dilution factor of 2.
brate constant of sample relative to that of its own control.
dnot detectable.
erate constant of sample with AO relative to that without AO.
00
~
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For the components with effects, several concentrations were listed as mentioned in
the text to show the concentration dependance. The ratio represented the rate constant of the
sample relative to the rate constant of its own control.

3.3

Spin Label Reduction in Sickle RBC

3.3.l

Reduction Rate in Sickle RBC
The reduction rate constants for the blood samples from 7 individual homozygous

sickle patients vary significantly from time to time. Some patients were followed up to 3
years during the 5-year period of this study (Table 7). The CV values ranged from 4.7 %
(over a period of 20 months) to 47.3 % (over a period of 17 months), with an average of
27.2 ± 15.1 %.
The average rate constants of the blood samples from 31 homozygous sickle patients
varied substantially, from 2.7 x 10-3 /min to 26.9 x 10-3 /min with an average value of
8.8 ± 6.4 x 10-3 /min and a CV of 72.5 %.

3.3.2

Spin Label Reduction in Sickle Lysate
Experiments similar to those studied for normal RBC were carried out for sickle RBC.

Reduction rates in sickle RBC were determined. Only those with rate constants higher than
those from normal were used to prepare membrane ghosts and lysate. Membrane and lysate
from normal RBC were used as controls. The systems were (1) Mb*(N) + lysate (N); (2)
Mb*(S) + lysate(N); (3) Mb*(N) + lysate(S); (4) Mb*(S) + lysate(S). Three sets of spin label
reduction rate constants of these 4 systems are presented in Figure 21. These data show that
within a single set of experiment, reduction rate constants from systems (3) and (4) were
always higher than those from systems (1) and (2). The rate constants from system (1) to
system (4) are 7.0, 8.7, 9.7, and 10.8 x 10-3 /min for the first set; 2.0, 2.4, 4.6, and 4.4 x
1o- 3 /min for the second set; and 2.1, 2.6, 4.2, and 4.5 x 10-3 /min for the third set.
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Table 7

Reduction Rate Constants from 7 Sickle Patients' Blood and the Variation of
Rate Constants within the Same Patient from Time to Time.

Patient

Date

ka 00- 3 /min)

Avg kb (10- 3 /min)

CV(%)

A

5-26-88
I-23-90
I-23-90

I2.54
I l.47
I l.69

I I.90 ± 0.57

4.7

6-08-88
6-2I-88

8.58
6.76

7.67 ± 1.28

I6.7

5-03-9I
5-09-9I

8.6I
6.66

7.64 ± 1.38

I8. I

I2-I5-88
8-29-89
II-20-90

7.97
4.48
8.I9

6.88 ± 2.08

30.2

6-04-87
6-I6-87
7-I4-87
7-28-87
9-0I-87
I-30-88
6-07-88
6-I6-88
6-28-88
9-06-89
9-I0-89
ll-I5-89
I2-06-89
I2-06-89

3.39
3.8I
4.92
3.50
4.04
3.78
1.37
3.52
4.42
1.79
5.28
3.95
4.87
5.5I

3.87 ± l.I8

30.6

6-04-87
6-I6-87
7-I4-87
7-28-87
9-0I-87
I0-06-88
9-06-89
I0-26-90

I 1.76
10.57
8.75
IO.I I
I2.10
I4.75
3.32
3.30

9.33 ± 4.IO

43.0

8-29-89
I-29-9I

3.42
6.85

5.14 ± 2.43

47.3

B

c
D

E

F

G

The average coefficient of variability (CV) of k for the same patient from time to time is
27.2 ± I5.I %.
ak is the pseudo first-order rate constant for spin label reduction.
bAverage k value of the same patient with standard deviation.
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Figure 21

Spin label reduction in sickle lysate.

The systems were (I) Mb*(N) +

lysate (N) ( D ); (2) Mb*(S) + lysate(N) (

~

(4) Mb*(S) + lysate(S) ( • ).

); (3) Mb*(N) + lysate(S) ( II );
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This suggests that intracellular components play a role in the reducing ability of sickle
RBC, and that the sickle membrane had no significant contribution to the high spin label
reduction.

3.3.3

Effects of Ascorbate Oxidase in Sickle Lysate
AO was also used to study ascorbate involvement in spin label reduction of sickle

RBC. Figure 22 shows the effects of AO (2 units/ml) on spin label reduction in two sickle
lysate systems. (1) Sickle lysate was mixed with AO before adding sickle membrane. The
reduction rate constant was 1.9 x 10- 3 /min without AO (Figure 22c ), and 0.1 x 10-3 /min with
AO (Figure 22a). (2) Intact sickle RBC was first spin labeled, then frozen and thawed. The
rate constant was 5.9 x 10-3 /min without AO (Figure 22d) and 0.5 x 10-3 /min with AO
(Figure 22b ). In both cases, at least 90 % of the spin label reductions were inhibited by AO.

3.4

Spin Label Reduction in Sickle RBC and Correlation with Antioxidant Activities

3.4.1

Antioxidant Levels
The levels of vitamin E and ascorbate and the activities of GPx, SOD, and CAT varied

from sample to sample in normal and sickle blood. Thus, the assays of these antioxidants were
performed with the same samples as used for spin label experiments. The vitamin E, GPx,
SOD and CAT assays were done on the blood samples of one set of sickle patients (n
while the ascorbate measurements were done on another set of sickle patients (n

=

=

19),

3).

The values of vitamin E varied from 5.91 to 37.63 for sickle samples, with an average
value of 16.95 ± 8.63 µg/gHb (n = 19), whereas the values from 3.19 to 17.69 were obtained
for normal samples with an average value of 10.10 ± 4.56 µg/gHb (n = 18). The experimental
uncertainties in vitamin E measurements exhibited an average standard deviation of 2.04
µg/gHb (n

=

55). The difference between the average values of normal and sickle samples

was statistically significant with p

=

0.005.
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Figure 22

The effect of AO on spin label reduction in sickle lysate. A semi-logarithmic
plot of the fraction of initial signal versus time for two sickle lysate systems.
(I) Sickle lysate was added to spin-labeled sickle membrane ( • ); (2) Intact

sickle RBC was first spin-labeled then frozen and thawed ( • ). The closed
symbols are from the samples without AO, and shaded symbols are from the
samples with AO. For system (I), the reduction rate constant for the sample
without AO was 1.9 x 10- 3 /min, with a correlation coefficient of 0.988
(line c ), and with AO was 0.1 x 10-3 /min, with a correlation coefficient of
0.476 (line a). For system (2), the rate constant was 5.9 x 10- 3 /min without
AO, with a correlation coefficient of 0.994 (line d), and 0.5 x l o- 3 /min with
AO, with a correlation coefficient of 0.788 (line b).
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The values of ascorbate varied from 13.55 to 28.39 for sickle samples, with an average
value of 19.24 ± 8.00 µg/gHb (n

3). The values varied from 2.77 to 11.68 for normal

=

samples, with an average value of 7.65 ± 4.52 µg/gHb (n = 3). The experimental uncertainties
in ascorbate measurements exhibited an average standard deviation of 0.88 µg/gHb (n = 6).
The difference between the average values of normal and sickle samples was not statistically
significant with p

=

0.094, probably due to the small sampling size.

The values of GPx level varied from 30.26 to 66.27 for sickle samples, with an average
value of 41.52 ± 8.76 µmole NADPH/min·gHb (n = 19). The values varied from 16.23 to 48.23
for normal samples, with an average value of 28.47 ± 7.35 µmole NADPH/min·gHb (n = 19).
The experimental uncertainties in GPx measurements exhibited an average standard deviation
of 0.94 µmole NADPH/min·gHb (n

=

23). The difference between the average values of

normal and sickle samples was statistically significant with p « 0.001.
The values of SOD level varied from 948 to 2,271 for sickle samples, with an average
value of 1,442 ± 404 units/gHb (n

=

19). The values varied from 931 to 2,787 for normal

samples, with an average value of 1,638 ± 535 units/gHb (n

=

19).

The experimental

uncertainties in SOD measurements exhibited an average standard deviation of 140 unit/gHb
(n = 23). The difference between the average values of normal and sickle samples was not
significant.
The values of CAT level varied from 93,385 to 167 ,104 for sickle samples, with an
average value of 114,838 ± 17,752 µmole H 2 0 2 /min·gHb (n

=

19). The values varied from

88,808 to 157,808 for normal samples, with an average value of 119,663 ± 19,324 µmole
H 2 0 2 /min·gHb (n

=

19). The experimental uncertainties in CAT measurements exhibited an

average standard deviation of 2,313 µmole H 2 0 2 /min·gHb (n

=

27). The difference between

the average values of normal and sickle samples was not significant.
A summary of average values is shown in Table Sa.
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Table 8a

Average and Standard Deviation Values of the Spin Label Reduction Rate
and Activities of Antioxidants of Normal and Sickle Cells.

Normal

Sickle

Sickle I

Sickle II

Set I

------------------------------------------------------------------------------Rate Constant
(10- 3 /min)
Vit E
(µg/gHb)
GPx
(µmole NADPH/min·gHb)
SOD
(units/gHb)
CAT
(µmole H 2 0 2 /min·gHb)

Avg
SD
n

3.08
± 1.11
19

8.64
± 6.32
19

4.01
± 0.60
8

12.02
± 6.49
11

Avg
SD
n

10.10
± 4.56
18

16.95
± 8.63
19

18.31
± 6.82
8

15.97
± 9.96
11

Avg
SD
n

28.47
± 7.35
19

41.52
± 8.76
19

44.03
± 11.49
8

39.70
± 6.08
11

Avg
SD
n

1639
± 535
19

1442
± 404
19

1654
± 512
8

1288
± 219
11

Avg
SD
n

119663
± 19324
19

114838
± 17752
19

121197
± 22578
8

110214
± 12432
11

Avg
SD
n

3.08
± 0.74
3

6.93
± 1.56
3

Avg
SD
n

7.65
± 4.52
3

19.24
± 8.00
3

Set II

Rate Constant
(10- 3 /min)

Ascorbate
(µg/gHb)
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Table 8b

Results* of Student t-test of Normal and Sickle Data

Normal

Normal
vs
Sickle I

VS

Sickle

Normal
vs
Sickle II

Set I
t
Rate Constant

(p)

t

(p)

t

(p)

-3.781 (0.001)

-2.235 (0.035)

-5.935 (<0.001)

Vit E

-2.992 (0.005)

-3.630 (0.001)

-2.172 (0.039)

GPx

-4.977 (<0.001)

-4.239 (<0.001)

-4.282 (<0.001)

SOD

1.273

(0.211)

-0.071 (0.941)

2.062 (0.049)

CAT

0.801

(0.428)

-0.179 (0.859)

1.452 (0.158)

Set II
Rate Constant
Ascorbate

-3.854 (0.018)
-2.183 (0.094)

*The number presented is the calculated t value and the corresponding probability in
parentheses.
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3.4.2

Correlation of Spin Label Reduction with Antioxidant Concentrations or Activities
Also shown in Table 8a are the corresponding spin label reduction rate constants of

the samples. The average rate constant of the first set (n

=

19) of sickle patients is 8.6 ± 6.3

x 10- 3 /min, whereas the rate constant for normal is 3.1 ± 1.1 x 10- 3/min. The average rate
constants for the second set (n = 3) are 6.9 ± 1.6 x 10-3 /min for sickle and 3.1 ± 0.7 x
10-3 /min for normal. The rate constants of these blood samples are in good agreement with
the rate constants of a larger population which were presented earlier.
The relationships between spin label reduction rate constant and the level of each
antioxidant of an individual blood samples are shown in Figure 23 for both normal and sickle
RBC. A strong positive correlation between ascorbate concentrations and spin label reduction
rates was obtained with r

=

0.929 and p

=

0.007 (Figure 23A). For normal cells, the level of

vitamin E (Figure 23B), GPx (Figure 23C), SOD (Figure 23D) and CAT (Figure 23E) did not
appear to correlate with the spin label reduction rates.

A Pearson correlation matrix

(Table 9a) showed little correlation between rate constants and the levels of vitamin E, GPx,
SOD and CAT in normal cells (p = 0.402, 0.573, 0.206 and 0.369, respectively). However,
slight negative correlations were obtained for the sickle cells between spin label reduction
rates and the level of GPx, SOD and CAT (Figures 23C, 23D, and 23E; Table 9b ), although
not very significant (p = 0.080, 0.072, and 0.082, respectively). No correlation was found
between vitamin E concentrations and spin label reduction rates in sickle cells (Figure 23B;
Table 9b).
To further determine whether there was a correlation between spin label reduction
rate and antioxidant levels in sickle cells, the sickle cells were divided into two groups
according to their spin label reduction rate constants. Sickle I had reduction rate constants
similar to those of normal cells (less than 6 x 10-3 /min) and Sickle II had reduction rate
constants significantly higher than those of normal cells (larger than 6 x 10- 3 /min).
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Figure 23

Relationships between spin label reduction rate constant and the level of each
antioxidant of an individual blood sample for both normal and sickle red
blood cells.

Ascorbate concentration versus reduction rate constant (A);

Vitamin E concentration versus reduction rate constant (B); GPx activity
versus reduction rate constant (C); SOD activity versus reduction rate constant
(D); CAT activity versus reduction rate constant (E). The different symbols
represent the results from different batches of normal blood, and different
letter labels represent the results from different sickle patients.
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Table 9a

Pearson Correlation Matrix for Normal RBC

RATE

CAT

GPx

SOD

RATE

1.000

CAT

0.218

1.000

GPx

-0.138

-0.388

1.000

SOD

-0.304

0.686

-0.256

1.000

VE

-0.211

-0.160

0.184

-0.001

Table 9b

Pearson Correlation Matrix for Sickle RBC

RATE
RATE

CAT

GPx

SOD

VE

1.000

VE

1.000

CAT

-0.422

1.000

GPx

-0.412

0.572

1.000

SOD

-0.409

0.665

0.301

1.000

VE

-0.032

0.355

0.394

0.270

1.000
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GPx activities in Sickle I and Sickle II (44.03 ± 11.49 and 39.70 ± 6.08 µmole
NADPH/min·gHb, respectively) remained significantly higher than that in normal (p «
0.001).

Similarly, vitamin E concentrations in Sickle I (18.31 ± 6.82 µg/gHb) remained

significantly higher than that in normal (p = 0.001), and vitamin E in Sickle II (15.97 ± 9.96
µg/gHb) was also higher than normal with p = 0.039. However, SOD activities in Sickle II
(1,288 ± 219 units/ml) appeared to be significantly lower than those of normal cells ( 1,639 ±

535 units/ml) with p

=

0.049.

Better negative correlations were found for the GPx, SOD and CAT levels with the
rate constants in Sickle II group (p = 0.049, 0.250 and 0.070) than in Sickle I group (p = 0.552,
0.867 and 0.805). The vitamin E levels showed no correlation with rate constants in either
Sickle I or Sickle II group.

CHAPTER IV
DISCUSSION
4.1

Signal Reduction of Membrane Spin Label in Intact RBC
In general, fatty acid spin labels are considered to be more stable in red blood cells

than in any other living cells which contain mitochondria or nucleus. In an earlier study on
parasitized erythrocytes using normal mice RBC as control, it was found that 5-DSA was
reduced by the electron transport chain in the parasite, but no reduction was observed in the
control, non-parasitized cells, over a time period of 30 min (Deslauriers et al., 1987). In this
study, the same spin label at a concentration of about 1.4 x 10-4 M was incorporated into the
membrane of fully CO-gassed human RBC, and its EPR signal was monitored at 37 °C over
a period of at least 2 hr. It was found that the EPR signal was reduced significantly by
intracellular components at the end of 2 hr. This observation led us to develop an EPR
method to evaluate the efficiency of radical reduction in membranes (Fung & Zhang, 1990).
Subsequent studies by others confirmed our finding of fatty acid spin label reduction in RBC
(Minetti & Scorza, 1991 ). These authors also found that when a cluster of spin label occurred,
there was a biphasic reduction profile: a faster reaction phase corresponding to the clustered
spin label reduction with a half - life of 60 min, and a slow reaction phase corresponding to
the reduction of the spin labels dispersed in membrane with a half-life of 170 min. The slow
half -life time agreed well with our average rate constant of 3.8 x 10-3 /min, corresponding
to a half-life time of about 180 min (t 1; 2 =In 2/k).
As stated in our published paper (Appendix I), since the measurements reflected the
extent of radical reductions occurring in cell membranes, the method could be used to
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measure the ability of intracellular antioxidant system to defend against oxidants in
membranes of RBC. A pseudo first-order radical reduction rate constant can be used as an
index for the effectiveness of intracellular antioxidant system toward the radicals in RBC
membranes. The experimental uncertainty for measuring the reduction rate constants is about
IO% (Table I). However, the spin label reduction rate constants obtained from normal RBC

under similar conditions varied from batch to batch, with a CV of about 45 %. Our published
work also indicated that the radical reduction depended upon the position of nitroxide radicals
on the hydrocarbon chain and the amount of oxygen in the system (Fung & Zhang, 1990).
The RBC-CO used for this study had practical advantages, although CO condition is
not a physiological condition. RBC-CO are stable under common experimental conditions for
at least several days since Hb has a very high affinity for CO; thereby, the complication of
having various species of Hb (e.g. oxyHb, deoxyHb, metHb, etc.) was eliminated.
Furthermore, the effect of re-oxidation of reduced spin labels by oxygen is also avoided.
It was noticed that the reduction rate constant of RBC sample with HbCO and cell-02 ,

which was obtained from CO-gassed RBC washed with un-gassed or 0 2 -gassed buffer once
after spin labeling (sample I), was higher than that of the fully 0 2 -gassed RBC sample
(sample 2) (Figure 20). A possible reason is that the CO in the cells of sample I is not
completely replaced by 0 2 after a single washing. Thus, the amount of 0 2 in sample I to reoxidize spin labels was less than that in sample 2. The results may also imply that the HbCO
and Hb0 2 have different contributions toward spin label reduction.

4.2

Position of Spin Label in Membrane
Fatty acid nitroxides, especially doxyl stearic acids, are highly lipophilic and readily

partition into the bilayer of cell membranes. It is generally accepted that spin labels are
randomly distributed in the two leaflets of the membrane bilayer, although the precise
distribution of fatty acid spin labels in the two leaflets is not clear. Our results showed that
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spin label translocation movement is relatively faster than the spin reduction, providing
additional evidence that the fatty acid spin labels distribute between two leaflets within the
experimental time period.
The study of spin label location in egg phosphatidylcholine vesicles using the nuclear
spin-lattice relaxation method revealed that the nitroxide groups on the stearic acids are
located nearer to the membrane exterior than the analogous positions of the phospholipid acyl
chains, and the nitroxide group of 5-DSA positions itself close to the head group of the
membrane bilayer (Ellena et al., 1988). The electron-electron double resonance study of
interaction between [1 4 N]-16-DSA and [15 N]-5-DSA pairs provided information on vertical
fluctuation of the 16-DSA nitroxide group toward the membrane surface. The cause of
vertical fluctuation is attributed to excursions of the terminal methyl region of the 16-DSA
toward the membrane surface. 5-DSA appears rotationally immobilized with less influences
by the length and unsaturation of lipid alkyl chains (Feix et al., 1984; 1987).

4.3

Kinetics Expression of Spin Label Reduction
It is known that the nitroxide (>N-O·) is generally reduced to the corresponding

hydroxylamine (>N-OH).

However, the reaction is reversible, and the product can be

oxidized back to the nitroxides under aerobic condition (Gaffney, 1976; Marsh, 1981; Chen
& Swartz, 1989). The global reaction may be represented by Eq. 4.3.1.

>N-O· + R ..,. >N-OH + 0

(4.3.1)

where R is a reducing agent which can reduce nitroxide to hydroxylamine, and 0 is the
oxidized form of R, or other oxidant which can re-oxidize hydroxylamine. Since the CO
treatment of systems was used in this study to limit the oxidation of hydroxylamine by 0 2 ,
the reverse reaction of nitroxide reduction by 0 2 could be ignored. Therefore, the reaction
rate for ( 4.3.1) can be expressed as
d[NO]/dt = kr[NO][R]

(4.3.2)
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where kr is nitroxide reduction (forward reaction of Eq. 4.3. l) rate constant. When [R] is not
changing significantly during the course of measurement, a pseudo first-order condition is
satisfied. Eq. 4.3.2 can then be written as
d[NO]/[NO] = kdt
or,
In {[NOJt/[NOJo} = -kt

(4.3.3)

Since the nitroxide spin label concentrations at different times were directly proportional to
the central peak heights (h) of EPR signal, Eq. 4.3.3 is equivalent to
In (htf h 0 ) = - kt
where ht is h at time t and h 0 is the initial h. Therefore, a pseudo first-order rate constant
for spin label reduction can be obtained from the slope of a linear fit of In (ht/h 0 ) vs time
plot. Since the pseudo first-order rate constant contains the term of concentration of reducing
agents, the rate constants obtained by this method reflect the reducing potency of the
corresponding components in RBC. This deduction provides the mechanistic background for
the apparent second-order rate constant when a specific component is isolated out to examine
its concentration dependence of a pseudo first-order rate constant.

4.4

Identification of RBC Intracellular Components that Reduce Membrane Spin Labels

4.4.1

Components with no Effect on Spin Labels in Membrane
In order to study RBC component(s) responsible for the spin label reduction in cell

membrane under CO condition, individual components or combinations of various
components were added to spin labeled membrane in CO-gassed buffer. As summarized in
Table 5, addition of excess (higher than the physiological levels) vitamin E, GSH, CAT, GPx,
SOD, NADH, NADPH, or HbCO individually to Mb* did not show any detectable reduction
over a period of 2 hr. The combination of some of these components with the Mb* also did
not show spin label signal reduction (Table 4).
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The concentrations of each component used for this study were considered from two
aspects: (1) experimental convenience and (2) appropriate concentration range to cover their
corresponding physiological values. The physiological values were chosen from the literature
reports for normal RBC. Usually, the concentrations of components added to the samples
were at least twice as high as their physiological values, some of them were even up to several
orders of magnitude higher.
Vitamin E is a membrane-bound molecule and actually exists in the isolated white
membrane ghost, at a concentration of 0.61 µg/mg protein, as determined by vitamin E assay.
The Mb* was stable for at least 24 hr. Thus it is not surprising that the added vitamin E did
not reduce spin label in membrane.
The antioxidant enzymes, SOD, CAT, and GPx, do not show reducing ability for
nitroxide spin label in membrane.
GSH and sulfhydryl groups are considered to be involved in some water-soluble
nitroxides reductions in rat tissue homogenates (Couet et al., 1985), in human erythrocytes
(Branca et al., 1988), and in human Hb solution (Perussi et al., 1988). However, the results
from both GSH depleted RBC and direct addition of GSH to Mb* showed that GSH is not a
major reducing agent responsible for 5-DSA spin label reduction (Figures 9 and 10). It should
be noted that at high concentration of GSH the pH value changed from neutral to acidic in
buffer with low phosphate concentration. To avoid acidic condition, either buffer with high
phosphate concentration or GSH solution neutralized by NaOH was used. However, both
cases had limitations. High salt concentration and osmolality of the system may significantly
alter the experimental condition. Therefore, it is unrealistic to raise the GSH concentration
above 40 mM, beyond the buffering capacity of high phosphate concentration buffer
(0.155 M NaH 2 P04 and 0.103 M Na2 HP0 4 ).
NADH and NADPH are common hydrogen donors in many biological reactions.
However, they did not provide hydrogens to nitroxides directly to reduce spin label in
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membrane.
Recently, it was reported that Hb in the ferrous form may be responsible for the
nitroxide reduction in human RBC based on the experiments of fatty acid spin labels directly
adding to Hb under hypoxia condition (Minetti & Scorza, 1991). In this study, the spin label
in a mimic system is similar to that in intact RBC. Our results show that HbCO does not
appear to be involved in the reduction of spin label in membrane. However, it is not clear
whether Hb0 2 is involved in the reduction.
The combinations of GSH, SOD, CAT, GPx, NADPH, and HbCO with Mb* did not
appear to be responsible for the spin label reduction in membrane (Table 4). It does not rule
out the involvements of these antioxidants in spin label reduction when combined with other
intracellular components.

4.4.2

Components with no Effect on Spin Labels in Membrane with Lysate
Since antioxidants in RBC coexist in the cellular compartment, any single component

which did not reduce spin label in isolated condition may be capable of reducing spin label
when mixed with other cellular components. Therefore experiments were designed to test the
effects on the reduction rate by systematically adding a single component to lysate. We found
that the addition of vitamin E, GSH, SOD, CAT, or GPx to Mb* and lysate to spin labeled
membranes did not enhance the reduction rate constant of membrane with lysate alone (Table
6). The fact that SOD, CAT, or GPx does not enhance the reducing ability even under the
condition when all the intracellular components are available may suggest that those enzymes
are not responsible for the spin label reduction.

4.4.3

Components with Effects on Spin Labels in Membrane
Ascorbate at concentrations higher than 0.1 mM, the upper limit of physiological

ascorbate concentration for normal RBC (Mehlhorn, 1991 ), produces detectable reduction of
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spin labels in membrane (Table 5).

The pseudo first-order rate constant of spin label

reduction is ascorbate concentration dependent (Figure 15), with an apparent second-order
rate constant of 3.1/min·M. When 1.0 mM concentration of ascorbate was added to the Mb*,
the first-order rate constant was about 3 x 10- 3 /min.

However, the reduction became

undetectable when 2.0 units/ml of AO was added to the system containing 1 mM ascorbate.
This suggests that (1) the spin label reduction caused by ascorbate can be inhibited by AO;
(2) when ascorbate is oxidized under this condition, it can no longer reduce the spin label in
membrane, which, however, seems to be inconsistent with the DHA finding, discussed below.
Interestingly, in the presence of 4.0 mM GSH the spin label reduction by ascorbate
was enhanced, although GSH itself had been demonstrated that it was not capable of reducing
the spin label directly. The enhancement was also ascorbate concentration dependent as the
apparent second-order rate constant increased from 3.1/mill"M to 4.7 /mill"M in the presence
of 4.0 mM GSH. Furthermore, in the presence of excess GSH, the spin label reduction by
ascorbate could no longer be suppressed by addition of AO.

The results from a UV

experiment revealed that ascorbate still underwent the oxidation catalyzed by AO in the
presence of GSH. Therefore, this suggests that the complex of the oxidized form of ascorbate,
probably DHA, with GSH has a high reducing ability and can reduce nitroxide spin labels in
membrane by a process which cannot be inhibited by AO. A similar postulate was proposed
based on a different approach (Mehlhorn, 1991).
DHA is considered as the oxidized form of ascorbate. In general, the amount of DHA
which exists in the biological systems is only about 2 - 5 % of total ascorbate (Okamura, 1980;
Tangney et al., 1989). DHA is susceptible to rapid decomposition, and can be reduced back
to ascorbate through DHA reductase (Rose, 1990), or by thiols (Mehlhorn, 1991). In addition,
DHA can spontaneously degrade by undergoing a biologically irreversible opening of the
lactone ring to form diketogulonic acid, which lacks antiascorbic or other metabolic activities
(Rose, 1990).
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It was observed that the kinetics of the spin label reduction by DHA differs from that

by ascorbate (Figure 19). The reduction profile has an initial lag followed by a fast reaction
phase. When first-order kinetics analysis was applied, the rate constants obtained were in the
same order as those corresponding to ascorbate. However, the concentration dependent rate
constant obtained for DHA (4.7 /min·M) was higher than that for ascorbate (3.1/min·M), but
almost the same as that for ascorbate in the presence of GSH (4.5/min·M).

Thus, the

aforementioned involvement of GSH in spin label reduction by ascorbate may be due to
GSH-DHA complex, which cannot be inhibited by AO.
It is likely that DHA is even more efficient in reducing spin label in membrane than

the reduction rate constants indicated, since the initial lag of the reduction profile of DHA
makes the obtained rate constant lower than it should be. In addition, the reduction rate
caused by DHA can be enhanced by addition of GSH. In the presence of 4.0 mM GSH, the
DHA concentration dependent rate constant obtained was 5.1/min·M, a moderate increase
from 4.5/min·M in the absence of GSH. Therefore, some of the roles of GSH in spin label
reduction are established by these experiments, although the precise mechanisms are still
unknown.

4.4.4

Components with Effects on Spin Labels in Membrane with Lysate

4.4.4.1 Involvement of NADH and NADPH
Both NADH and NADPH did not produce any detectable reduction of spin label in
the absence of lysate. However, the addition of 720 µM of NADH or NADPH to the system
with membrane and lysate increased the rate constant significantly (Table 6).

The rate

constants obtained from the systems with various concentrations of NADH or NADPH showed
linear concentration dependence, with an apparent second-order rate constant of 0.6/min·M
or 2.2/min·M, respectively.

However, at the physiological concentration of NADH and

NADPH in lysate (about 20 µM), the NADH and NADPH contributions to the rate constant

112
are small, of only 1.2 x 10- 5/min and 4.4 x 10- 5/min respectively. The average rate constant
for spin label reduction, however, is in the order of 10- 3 /min. Thus, NADH and NADPH are
probably cofactors for regenerating ascorbate in the lysate, as will be discussed later.

4.4.4.2 Ascorbic Acid is the Major Reductant in RBC Lysate
The role of ascorbate in biological processes has often been evaluated with AO. It
should be pointed out that AO is not capable of penetrating the membrane and accessing the
sealed membrane compartment.

Thus, the enzyme inhibitory effects cannot be used to

elucidate the role of ascorbate as a free radical scavenger in tissue homogenates or cell lysate
that contain resealed membrane (Mehlhorn, 1991). In this study, AO was added to lysate or
other systems with ascorbate prior to the addition of Mb*, to avoid the potential complication
of ascorbate that might be entrapped in AO-inaccessible resealed membrane. It was found
that at least 90 % inhibition of spin label reduction could be achieved by introducing AO into
cell lysate (Figure 16). Therefore, ascorbate is a major reductant for 5-DSA reduction in
normal RBC.
In the system with lysate, ascorbate yielded an apparent second-order rate constant
of 7.6/min·M, significantly higher than that of 3.1/min·M in the absence of lysate and GSH.
It is also higher than that of 4.7 /min·M in the presence of 4.0 mM GSH but absence of lysate.
It shows that components other than GSH in the lysate are enhance the ascorbate reducing

ability.

4.4.4.3 Regeneration of Ascorbate in RBC Lysate
In RBC, ascorbate accumulated when the cells were incubated with DHA, and the
DHA reduction to ascorbate in RBC, which was shown to be mediated by enzymatic reactions,
was greater than that by equivalent concentrations of GSH in buffer (Christine et al., 1956).
It has been suggested that exogenous ascorbate may be internalized by first oxidizing
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ascorbate to DHA on or near the surface of RBC, then migrating DHA through the lipid
portion of the cell membrane, and finally reducing DHA back to ascorbate within the cell
(Wagner et al. 1987). Furthermore, the entrapment of ascorbate seemed to be enzymatically
mediated, but it is not clear whether the rate of entrapment is controlled by enzymes (Wagner

et al. 1987).
Ascorbate reacts with free radicals resulting in a relatively stable intermediate,
ascorbate free radical (AFR), which is a biologically non-hazardous free radical, and can
serve both as a one-electron oxidant and as a one-electron reductant (Alcain et al., 1991 ).
AFR can be further oxidized in a slow autoxidation to DHA which is susceptible to rapid
decomposition. AFR can also be reduced, enzymatically by AFR reductase, to regenerate
ascorbate. DHA can be reduced back to ascorbate through DHA reductase (Rose, 1990), or
by thiols (Mehlhorn, 1991 ).
Choi and Rose (1989) found that in the homogenates of rat colon, NADPH was the
most effective cofactor in reducing DHA to form ascorbate as compared with other reducing
equivalents such as GSH and cysteine. Nevertheless, the regeneration of ascorbate from AFR
is carried out by the NADH-dependent AFR reductase as a part of the transmembrane redox
system, which has been found in some biological cells and tissues (Alcain et al., 1991). To
date, the efficiency of ascorbate regeneration in human RBC has not yet been resolved
(Mehlhorn, 1991). A summary of ascorbate regeneration scheme is shown in Figure 24.
In this study, the finding that the pseudo first-order rate constant of spin label

reduction is NADH and NADPH dependent may suggest a regeneration of ascorbate in the
RBC lysate. Assuming that the mechanism elucidated in Figure 24 is suitable for ascorbate
regeneration in RBC, the effects of adding NADH or NADPH to lysate on the spin label
reduction rate constant may be related to the regeneration of oxidized ascorbate. As shown
in Figure 24, the reaction rate of the disappearance of ascorbate (AA) can be expressed as
-d[AA]/dt

=

k 1[AA][NO] - k_ 1[AFR][NADH] - k 3 [DHA][NADPH]

(4.4.4.3.1)
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Figure 24

Scheme of ascorbate regeneration.

AA, ascorbate; AFR, ascorbate free

radical; DHA, dehydroascorbate; NO, nitroxide radical; NOH, hydroxylamine;
NAD(H), oxidized (reduced) forms of nicotinamide adenine dinucleotide;
NADP(H), oxidized (reduced) forms of nicotinamide adenine dinucleotide
phosphate. The reduction of NO by AA yields AFR. Then, AFR is either
enzymatically reduced back to AA or auto-oxidized to DHA, while DHA can
be also enzymatically reduced to regenerate AA.
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Then, when a steady state is achieved, we have
-d[AA]/dt = 0, and
k 1[AA][NO]

=

k_ 1[AFR][NADH] + k 3[DHA][NADPH]

(4.4.4.32)

For a pseudo first-order reaction rate constant, we have
k = k 1[AA]

(4.4.4.3.3)

Combining (4.4.4.3.2) and (4.4.4.3.3),
k

=

k_ 1[AFR][NADH]/[NO] + k 3 [DHA][NADPH]/[NO]

(4.4.4.3.4)

A plot of k vs added [NADH] would be linear and yield a slope as (k_ 1[AFR]/[NOJ).
Similarly, a plot of k vs added [NADPH] would also be linear and yield a slope as
(k 3[DHA]/[NO]).

The results from this study showed that the spin label rate constants

increased linearly as the concentrations of NADH or NADPH was increased. These are in a
good agreement with the scheme in Figure 24. Moreover, the slope from the plot of rate
constant vs NADPH concentration is relatively steeper than that from the plot with NADH
(Figure 14), probably indicating that more ascorbate is regenerated through the DHA
reduction pathway than the AFR reduction pathway.
Experimentally, it has been shown that the NADPH treated lysate had a higher
concentration of ascorbate than its control sample (Figure 18). In addition, the fact that in
the presence of 720 µM NADPH the spin label reduction of membrane and lysate was only
inhibited partially (-50 %) by AO (Table 6) may also support the ascorbate regeneration
mechanism. Since AO oxidizes ascorbate to DHA, which can be reduced back to ascorbate
by NADPH, the introduction of a large amount of NADPH will establish an equilibrium in
which a considerable level of ascorbate could be retained in samples treated with AO.

4.5

Speculations on 5-DSA Spin Label Reduction by Ascorbate in RBC
As discussed in the previous sections, it is conceivable that the spin label molecules

are dispersed in the bilayer of membrane. It was also concluded that ascorbate is a major
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reducing agent. However, to accept such a conclusion, a critical question must be resolved:
How can the lipophilic spin label, with its nitroxide group buried in the membrane, be
reduced by water-soluble ascorbate in the cytoplasm? One way or another, the spin label and
the reducing agent (ascorbate) should encounter each other. Some possibilities are presented
to account for this:
1)

There is a fast equilibrium of spin label distribution between membrane and
cytoplasm, and only those in cytoplasm are reduced by ascorbate.

2)

All spin label molecules are dispersed in the bilayer of membrane, and no
reduction occurs when they are buried in the lipid bilayer.

However, a

vertical motion of the 5-DSA may bring the nitroxide group of the spin label
close to the membrane bilayer surface, and the reduction occurs when the
nitroxide is close to the membrane surface.
3)

Spin label is located in membrane, and ascorbate can penetrate into the bilayer
to a certain depth depending upon the hydrophilicity of the environment.
Therefore, the reduction rate is controlled by the effective concentration of
ascorbate in the bilayer of the membrane.

For the first hypothesis, there should be a considerable amount of free spin labels in
the cytoplasm in order to achieve a substantial reduction rate. Therefore it would have
noticeable sharp signals, characteristic rapid isotropic motions, in the EPR spectra. However,
no such signals were observed in this study (Fung & Zhang, 1990). Although it was reported
that such peaks were observed (Minetti & Scorza, 1991), the peak size seems too small to
account for the substantial reduction rate.
For the second hypothesis, it is possible to have a considerable concentration of
ascorbate near the membrane surface. The lipid head groups in the bilayer consist of about
10 atoms, including a variety of polar groups that can function as either hydrogen-bond
acceptors or donors to accommodate molecules with hydroxyl groups, such as ascorbate
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molecules. The spin label reduction rate is limited by the vertical motion of spin labels in the
membrane bilayer, since only the spin labels with their nitroxide groups close to the
membrane surface can contact with ascorbate and be reduced. It has been reported that both
5-DSA and 16-DSA in model membrane can quench a fluorescent probe in which the
fluorophore is at second position of the fatty acid acyl chain near the head group. In this
case, the quenching efficiency for 5-DSA is higher than that for 16-DSA (Wardlaw et al.,
1987). This suggests that the vertical motions of fatty acid acyl chains occur in the bilayer,
which in extreme cases may result in the terminal methyl group approaching to the bilayer
surface by chain bending. One would expect that the deeper the nitroxide group on the fatty
acid chain, the less chance to get close to the membrane surface. Consistent with this, our
results showed that the reduction rate constant for 16-DSA in CO-gassed intact RBC was only
about half of the value for 5-DSA (Fung & Zhang, 1990).
For the third hypothesis, it is proposed that the distribution of ascorbate in the
membrane is a function of hydrophobicity, i.e. the higher hydrophobicity the environment,
the lower concentration the ascorbate. This mechanism can also explain the observation that
when the nitroxide group is located deeper in the bilayer, the reduction rate is slower. It has
been suggested that the principal rate-limiting step for the reduction of nitroxide moiety deep
in the membrane of tissue cells appeared to be the diffusion of reducing equivalents from the
surface into the hydrocarbon region of the membrane (Chen et al., 1988). However, the
reducing equivalents responsible for the spin label reduction in these cells were from the
mitochondrial respiratory chain. It will be interesting to find out whether ascorbate is actually
able to diffuse into hydrophobic environment.
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4.6

Efficiency of Radical Reduction in Normal and Sickle Cell Membranes

4.6.1

Significant Difference of Spin Label Reduction between Normal and Sickle RBC
The results showed that the average spin label reduction rate constant of sickle RBC

from 31 patients (8.8 ± 6.4 x 10-3 /min) was significantly higher than that obtained from 64
batches of normal RBC (3.8 ± 1.7 x 10-3 /min). It appears that sickle RBC could reduce
nitroxide radicals in cell membrane more efficiently than normal RBC. This has not been
reported by others to date and is a surprising finding.
Although the reduction rate constants of both normal and sickle RBC varied from
batch to batch and patient to patient, the sickle RBC from 31 patients had a much wider
range of reduction rate constants than normal RBC. The spin label reduction rate constants
of some sickle patients' RBC were similar to those of normal RBC, while others were
significantly higher than those of normal RBC.

Rate constants of blood samples from the

same patient could also vary significantly from time to time (Table 7). It will be interesting
to correlate the radical reduction rate with the severity of symptoms experienced by
homozygous sickle cell disease patients. The sickle bloods used in this study were obtained
from patients under different conditions such as during clinical visits, hospitalization, or
special arrangement. The clinical symptoms of each patient at the time when blood samples
were collected were not well documented. Some sickle patients were in pain crisis, and some
were asymptomatic. The Hb electrophoresis allowed us to confirm that all of the blood
samples subjected for this study were homozygous SS, and the patients had not undergone
transfusion for a period of time. Based on the limited information on the clinical symptoms
for a few patients, it appears that the higher reduction rate constants may be attributed to
more severe sickle syndrome.
Smoking habits, medication, or the gender of the blood donor may also affect the
radical reduction rate.
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4.6.2

Spin Label Reduction in Sickle RBC Lysate
The results showed that the lysate prepared from sickle RBC which have high spin

label reduction rate constants also gave higher reduction rates than lysate prepared from
normal RBC, in spite of spin labels in normal or sickle membrane (Figure 21). It clearly
demonstrated that the antioxidant components were located in the cytoplasm instead of
membrane, and it is the same for both normal and sickle cells. It also suggests that sickle
membranes do not play an important role in the spin label reduction.
Furthermore, the fact that AO can suppress at least 90 % of the reduction rate constant
in sickle lysate (Figure 22) indicates that ascorbate is also a major reducing agent for sickle
RBC.

4.7

Effectiveness of Antioxidant Activities on Spin Label Reduction

4.7.l

Levels of Antioxidants in Normal and Sickle RBC
In general, SOD, CAT, GPx and vitamin E are considered as principal antioxidants

in human erythrocytes (Chiu et al., 1982; Hebbel, 1986). Among them SOD and CAT are
located within the cytoplasm, while Vitamin E is membrane located, and GPx is weakly
membrane bound (Duchon & Collier, 1971; Ursini & Bindoli, 1987). The activities for each
of the antioxidant enzymes (SOD, CAT, GPx) in normal RBC have been reported in a wide
range by different investigators, in part due to different methods used for enzyme assays
(Faraji et al., 1987; Schacter et al., 1988; Goldstein & Czapski, 1991). Enzyme activities of
normal RBC measured in this study were well within the range of the values reported in the
literature. The average concentration of vitamin E in normal RBC was also similar to the
reported value which was obtained using the same method (Chiu & Lubin, 1979).
The activities of SOD, CAT and GPx and the level of vitamin E in sickle RBC have
been reported as different from normal RBC. However, the reported results are not consistent
in the literature. For example, it has been reported by Das and Nair (1980) and Beretta et al.
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( 1983) that sickle red blood cells had higher SOD activities and lower CAT activities than
normal RBC. However, Schacter et al. (1985; 1988) reported that sickle cell anemia patients
with moderate and severe symptoms had lower SOD activity than those with mild symptoms
and normal controls. Reported GPx activities in sickle cells are also controversial, as Das and
Nair (1980) reported lower activities while others reported higher activities (Chiu & Lubin,
1979; Beretta et al., 1983; Lachant et al., 1983).

The level of vitamin E in sickle RBC as

compared with normal RBC has also not been consistent, since both lower (Chiu & Lubin,
1979) and higher (Tangney et al., 1989) levels were reported. The inconsistency about the
differences of the antioxidant activities between normal and sickle RBC probably stem from
different population groups studied.
To avoid such a problem, in this study, the levels of these four antioxidants were
measured using the same blood samples, which consisted of a relatively large population and
their spin label reduction rate constants also represented a wide range of rate constants from
a large population.
The results obtained from this study show that the average activities of GPx and the
level of vitamin E in sickle RBC were significantly higher than those in normal RBC (p =
0.001, 0.005). The average activities of SOD and CAT in sickle RBC were lower than normal
RBC, but the differences were not statistically significant (p = 0.21, 0.43). Our results of high
GPx activities in sickle RBC are in accordance with the findings by most authors (Chiu &
Lubin, 1979; Beretta et al., 1983; Lachant et al., 1983). Increased vitamin E levels found in
sickle RBC is in agreement with the finding by Tangney et al. (1989).
In RBC, besides the four antioxidants discussed above, ascorbate is considered as a
reducing agent. Its abundance (about 0.1 mM) also enhances its importance in the system.
Therefore, its function in the system is not negligible.
Although the amount of ascorbate in normal blood distributed to erythrocytes is about
the same as to plasma (Barkhan & Howard, 1958), the role of ascorbate as antioxidant is
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generally studied in blood plasma (Jain & Williams, 1985; Frei et al., 1989). In erythrocytes,
ascorbate is considered as a synergist in sparing and maintaining the concentration of vitamin
E, thereby preventing lipid peroxidation (Niki, 1991). On the other hand, ascorbate is
suspected to function as a prooxidant in the presence of ferric ion by reducing ferric ion to
ferrous ion which decomposes peroxides to generate hydroxyl radicals (Hebbel, 1986), though
the prooxidant action of ascorbate was only observed in some model experiments with free
iron (Block et al., 1991).
In sickle cell studies to date, the concentrations of ascorbate in sickle patients have all
been measured in their blood plasma (Akinkugbe & Ette, 1983; Jain & Williams, 1985;
Adelekan et al., 1989), serum (Tangney et al., 1989), and leukocytes (Chiu et al., 1990). Some
reports showed that sickle patients had significantly lower ascorbate levels in plasma or
leukocytes than normal controls (Akinkugbe & Ette, 1983; Jain & Williams, 1985; Chiu et al.,
1990), while others reported that there were no significant differences (Adelekan et al., 1989;
Tangney et al., 1989). Since the sickle patients appeared to have an adequate intake of dietary
vitamin C, the cause of plasma ascorbate deficiency in sickle patients was attributed to
increased ascorbate utilization (Chiu et al., 1990). In the present study, the levels of ascorbate
measured from some of the sickle patients' RBC appear to be higher than those from normal
RBC. It could be speculated that more ascorbate partitioned into sickle cells than into normal
ones, thereby giving less ascorbate in sickle blood plasma, as found by many investigators.
It is also interesting to note that the storage of normal blood affected the distribution of

ascorbate between plasma and cells.

As reported, after a period of several hours the

concentration of ascorbate in plasma decreased, while that in cells increased (Lowik et al.,
1991 ). Similarly, it was found that vitamin E levels in plasma were significantly lower for
adult patients with sickle cell anemia than those of healthy normal black adults. However,
the levels of vitamin E in sickle RBC of the same subjects were significantly higher than those
in the normal RBC of control subjects (Tangney et al., 1989).
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A clear understanding of the physiology of ascorbate in blood is necessary for a more
detailed analysis of our findings.
In summary, the activities of membrane bound antioxidants GPx and vitamin E are
higher, while those of cytoplasm antioxidant enzymes SOD and CAT are lower, in sickle RBC
than in normal RBC. In addition, the concentration of ascorbate in sickle RBC is higher than
in normal RBC. The relationships among them and spin label reduction will be discussed in
the following section and the overall radical reduction mechanism of the antioxidant system
will be proposed in section 4.7.3.

4. 7.2

Correlations between Spin Label Reduction and Antioxidant Activities
The purpose of measuring antioxidant activities or concentrations in this study is not

only to compare the antioxidant levels of normal RBC with those of sickle RBC, but also to
determine the effectiveness of these antioxidants on the spin label reduction.
Among these antioxidants, ascorbate displayed a strong positive correlation between
its concentrations and spin label reduction rate constants (Figure 23A). In addition, at least
90 % of the reduction could be inhibited by adding an adequate amount of AO. Therefore,
the high 5-DSA spin label reduction rate in some sickle cells can be attributed to the high
ascorbate concentration in these sickle RBC.
On the average, sickle RBC samples that had higher reduction rate constants than
normal RBC also had higher GPx activities and vitamin E concentrations, but lower SOD
activities than those of normal RBC. It has been reported that RBC from sickle patients with
moderate and severe symptoms gave low SOD activity (Schacter et al., 1985; 1988). This is
in agreement with our finding that the sickle RBC, which have higher reduction rates, also
have lower SOD activities. It supports our speculation that sickle patients who have more
severe symptoms may have higher reduction rates.

Based on these findings, it may be

suggested that the relationship among those antioxidants are fully expressed when the sickle
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cell symptom is severe.

4. 7 .3

A Viewpoint on the Antioxidant System in Sickle RBC
A single mutation of the ,86-Glu to Ala of Hb causes sickle disease. The existence of

sickle disease is believed to be the result of evolution, driven by malaria, a fatal disease
mainly present in the African continent.

Besides the single mutation on the Hb, other

alterations also occurred in sickle cells as consequences, proceedings, or parallel developments.
Here, we do not intend to trace back when and why sickle disease evolved. However, the
view of evolution may help us to understand the antioxidant system in RBC. Based on the
results obtained in this study and other information about sickle disease available in the
literature, we may be able to compose an hypothesis of the antioxidant system in sickle RBC
and its alteration from normal RBC.
It has been reported that more superoxide radicals are generated in sickle cells than

in normal ones due to the abnormalities in sickle Hb (Hebbel et al., 1982). As a consequence,
the sickle RBC are exposed to more severe free radical damage. Increased oxidation of lipid
and protein constituents of the sickle membrane has been demonstrated (Chiu et al., 1982;
Rank et al., 1985). For RBC to overcome this problem, the most economical way probably
is to maintain a higher concentration of ascorbate in the cytoplasm, since ascorbate is a
general reducing agent and ascorbate is partially responsible for the 0 2 - reduction with the
mechanism parallel to the SOD action (Nishikimi, 1975; Nandi & Chatterjee, 1987). This may
explain why ascorbate concentration is lower in blood plasma and higher in cytoplasm of
sickle RBC than that of normal controls. On the other hand, the lower activity of SOD in
sickle cells than in normal cells could be due to the higher concentration of ascorbate in sickle
cells.
While not actually a free radical, H 20 2 is readily generating other free radicals and is
capable of crossing membranes to initiate lipid peroxidation chain reactions. In the presence
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of transition metals, H 20 2 can be converted to ·OH, which is highly active and can damage
almost any biological molecule it encounters. It is believed that ·OH is one of the most potent
oxidants attacking red cell membrane and causing hemolysis (Chiu et al., 1982). Therefore,
membrane bound antioxidants are very important to protect membrane lipids and proteins.
In sickle cells, it is also known that there is an abnormal amount of membrane bound
heme (Fischer et al., 1975) and an increased susceptibility of membrane peroxidation (Das &
Nair, 1980). The higher ascorbate concentration can accommodate most of free radicals in
the cytoplasm. But those in the membrane must be taken care of by vitamin E, which is
membrane bound, and GPx, which is weakly membrane bound (Duchon & Collier, 1971;
Ursini & Bindoli, 1987). As observed in this study and by some other investigators (Beretta

et al., 1983; Lachant et al., 1983; Tangney et al., 1989), the vitamin E concentrations and GPx
activities are higher in sickle cells than in normal cells.
Evolution is fascinating, and nature sometimes has its own way to overcome the
disadvantages and to eliminate the defects that occurred during the process.
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Abstract-The erythrocyte defense system against cellular oxidants is complex and efficient. Free radicals generated in cell
membranes, however, are relatively sequestered from the cell's antioxidant mechanisms. When an oxidant challenge exceeds the
capacity of the erythrocyte's antioxidant system, membrane damage may occur, causing red cell desttuction and hemolytic anemia.
In this srudy. we present a method for monitoring radicaJ reduction in erythrocyte membranes, using fatty acid spin labels with
nitroxide radicals on the hydrocarbon chams. About 50 !J.L of packed (about 5-<i x 10 8). carbon monoxide <COJ-gassed red blood
cells are used. The electron paramagnetic resonance signals of the 5-doxylstearic acid spin labels in the intact cells are obtained as a
function of time. at 37°C over a period of 2 h. The pseudo fITTt-order rate constant for reduction of the spin label in normaJ adult intact
cells under our experimental conditions is .+.3 ::: J .3 x 10- 3/min. The reproducibilicy and variability of the measurements are
discussed. Since the measurements we describe reflect the extent of radical reductions occurring in cell membranes, we suggest that
this method can be used to measure the ability to defend O.'Htlants in membranes of erythrocytes with defective antioxidant systems.
This method is pantcularly useful for measunng the modification of the antioxidant system toward radicals in membranes by drugs,
chemicals, or environmental toxins.
Keywords-Fatty acid spin labels. Erythrocyte membranes, Antioxidants, Radical reduction, Free radicals

tered from the cell's antioxidant mechanisms, which.
with the exception of vitamin E, are largely cytoplasmic. 8 ·9 Thus, even mildly defective antioxidant systems
may cause extensive damage in erythrocyte membranes.
For example, in sickle cell anemia (SCA), some of the
antioxidant systems appear to be abnormal in sickle
erythrocytes, 10- 13 and erythrocyte oxidation might underlie the development of some of the known abnormal
membrane properties. 8 Generally, individual enzyme
activities were measured in the SCA studies. For example, it has been reported that SCA pacients have increased glutathione peroxidase activities, 11 but decreased
superoxide dismutase activities, 13 or decreased glutathione
peroxidase activities and increased superoxide dismutase
activities. 12 However, it is difficult to assess the effec·
tiveness of the concerted actions of the intracellular free
radical scavenging enzyme systems toward radicals in
membranes. Yet an understanding of the actions of the
erythrocyte antioxidant system toward radicals in membranes, or lipophilic oxidants, is essential for the study
of red blood cell physiology and pathophysiology.
Radicals are generally difficult to study. For exam·
pie, peroxyl radicals may participate in chain reactions.
and are thus difficult to study experimentally. Paramag·

L'ITRODUCTION

Free radicals are formed in biological systems by various endogenic or exogenic compounds, and play an
important role in diseases and aging. Erythrocytes have
been extensively studied as a target for oxidative damage. 1- 3 Hemoglobin (Hb) oxidation produces radicals.'· 5
which could enhance intracellular and membrane protein
oxidation and lipid peroxidation, 6 but probably by different mechanisms, since the two processes can occur
independently. 7 Drugs or xenobiotics that can undergo
oxidation-reduction reactions in erythrocytes may also
generate radicals. When an oxidant challenge exceeds
the capacity of the erythrocyte's antioxidant "·,tern.
membrane damage may occur to cause red cell cestruction and hemolytic anemia. 2
The erythrocyte defense system against cellular oxidants is complex and efficient, and consists of a series
of interrelated processes. The defense system against
oxidants in the cell membrane is less effective since
radicals in the membrane would be relatively sequesAddress correspondence to Leslie W.-~I. Fung. Department of
Chemistry, Loyola University of Chicago, 65~5 :-J. Shena.lJ'I Road,
Chicago. IL 60626.
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netic nitroxide radicals (> NO-) resemble ground state
oxygen (-0-0•), and may thus compete with oxygen in
free radical addition reactions. The nitroxide spin-pairing products are expected to be less reactive. and thus
easier to study. Therefore, the nitroxides are potentially
useful in studying oxygen involvement in free radical
reactions. 14
The reductions of various nitroxide spin labels, to
hydroxylamines, which have no electron paramagnetic
resonance (ESR) signal, have been reported in various
biological systems. For example, the reductions of fatty
acid spin labels in membranes which consist of electron
transfer systems have been studied. l4-lS The intracellular reduction of water-soluble spin labels in erythrocytes
have also been observed. 19 - 24 However, fatty acid spin
labels have been considered stable in erythrocytes. for
example in erythrocytes from normal mice over time
periods of 30 min. 23
We have monitored the ESR signals from fatty acid
spin labels in human erythrocyte membranes for a
longer period of time under somewhat different conditions than the above-mentioned work. and observed
reduction with a pseudo first-order initial rate constant
of about 4.3 :±: 1.8 x 10- 3/min. In this report, we
show that nitroxide radicals on fatty acid spin labels
located in the membranes of intact erythrocyte are
reduced by intracellular antioxidant systems, and present
a method to evaluate the efficiency of cellular antioxidant systems for radicals in erythrocyte membranes.

MATERIALS AND METHODS

Red blood cells
Fresh, normal, adult human red blood cells (RBCs)
were obtained from a local blood bank. The RBCs were
washed, at 4°C, with an isotonic buffer solution of either
5 mM sodium phosphate buffer with 150 mM NaCl at
pH 8.0 (PBS), or sodium phosphate buffer (l .4 mM
NaH 2 P0 4 and 8.6 mM Na 2 HP0 4 ) with 135 mM NaCl, 5
mM KC!, and 11 mM glucose at pH 7 .4 and osmolality
290-300 mosmol/kg (BSKG). The buffer solutions were
gassed with carbon monoxide (CO) at 4°C before use.
The blood cells were assessed optically. using optical
cells with very narrow light paths (0.0! mm). at wavelengths of 540 and 569 nm to ensure that the Hb
molecules inside the cells were fully CO-liganded 05
Generally, 30 min of bubbling CO gas into the cold
buffer immediately before use provided sufficient CO
gas in the buffer to fully ligate the Hb molecules with
CO. For oxygenated cells, Orgassed buffers. instead of
CO-gassed buffers, were used to wash the RBCs. Optical spectra of these cells at 54 l and 577 nm were
obtained to ensure that all Hb molecules were 0,liganded. 25
-

Spin-labeled RBC
Fatty acid nitroxide spin probes. 5-doxylstearic acid
or 16-doxylstearic acid, were purchased from either
Syva (Palo Alto. CA) or Aldrich (Milwaukee, WI) and
used without further purification. The spin labels were
stored in ethanol solution at a concentration of about 0.5
mg/rnL. Spin labels in ethanol (I rnL) were introduced
into a small container, and ethanol was evaporated to
dryness with nitrogen, at room temperature, in the dark,
to give a thin film of spin labels on the container walls.
About 10 rnL of buffered, fatty-acid-free bovine serum
albumin (BSA) (2.2 mg/rnL) was added to the container. The solution was stirred for at least 4 h at room
temperature to give a spin-labeled BSA solution. with a
spin label concentration of about 5 x 10- 5 M, as
determined by ESR measurements. 50 µ.L packed RBC
with hematocrit greater than 95% (about 5--0 x 108
cells) were mixed with 1 rnL of the spin-labeled BSA
solution for about 30 min at 4°C, and the mixture was
washed with cold buffer to remove excess spin-labeled
BSA. To avoid echinocvte formation, 26 ·27 the fattv acid
spin labels were not mi;ed directly with red blood, cells.
The spin-labeled cells (about 20 µ.L) were packed in
small 50 µ.L hematocrit capillaries, which were used as
ESR sample tubes, by a microhematocrit centrifuge for
3 min at 4°C. The heights of the packed cells in the
hematocrit tubes were at least 2 cm to ensure proper
ESR measurements. About 30-50 µ.L packed red blood
cells are needed to give about 20 µ.L spin-labeled cells.
If the ESR spectrometer is equipped with a loop-gap
resonator28 to give better signal-to-noise ratios. about 10
µ.L packed cells will be needed to prepare sample for a
single ESR measurement. The total sample preparation
time was about 2 h.

Hemolysares
Centrifuge tubes containing washed, CO-gassed RBCs
with hematocrit values greater than 95% were immersed
in liquid nitrogen for about 30 s to allow complete
freezing of the cells, followed by immersion in a water
bath at room temperature for about 2 min. The thav.ed
samples were then centrifu11ed for about I0 min ar
30.000 g and 4°C. The sup~matant in each tube was
removed. stored on ice, and used within 5 min.

Membranes and spin-labeled membranes
White membrane ghosts were prepared from washed
cells. Cells were lysed and washed with 5 mM sodium
phosphate buffer at pH 8. 29 Membrane concentrations
were represented by protein concentrations. whi<:h were
determined by modified Lowry method. 30
Spin-labeled membranes were obtained by labeling
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white membranes (4.3 mg/mL) with 5-doxylstearic acid
labels to give a spin label concentration of about 1.4 x
10 - 4 M." The membranes were not labeled with spinlabeled BSA solution, as was done for the RBC samples, since spin-labeled BSA strongly adsorbs to isolated
ghosts, but not to intact red cells. 32

NADPH, vitamin C and vitamin £-treated samples
Beta-nicotinamide adenine dinucleotide phosphate,
reduced form (NADPH), purchased from Sigma (St.
Louis, MO). was dissolved in CO-gassed PBS buffer to
give a concentration of 2.15 mM. Vitamin C (Lascorbic acid) solution at a concentration of 20 mM,
from Sigma. was freshly prepared with CO-ga5sed, high
phosphate concentration buffer (0.155 M NaH,P0 4 and
0.103 M Na2 HP04 ) to maintain the pH value of the
vitamin C solution at about 8.0. Vitamin C solution was
highly acidic in PBS solution. About 30.5 mg of vitamin
E (d-a-tocopherol), from Kodak (Rochester, NY), was
dissolved in dehydrated ethyl alcohol, dried to a thin
film with nitrogen gas, and suspended in 1 mL of
CO-gassed PBS by swirling with glass beads followed
by sonication for about 10 min immediately before use.
About 20 µL of NADPH solution, 10 µL of vitamin C
or vitamin E with equal amounts of buffer, or 10 µL of
vitamin C plus 10 µL of vitamin E were mixed with 20
µL hemolysate and 20 µL spin-labeled membrane and
used for ESR measurements immediately. Control samples consisted of 20 µL of PBS instead of NADPH,
vitamin C, or vitamin E solution. The final NADPH
concentration in the sample containing hemolysate was
about 0. 74 mM, assuming that the hemolysate contained
about 0.02 mM NADPH. 33 The final concentration of
the vitamin C in the sample was 3.3 mM. assuming that
the hemolysate contained about 0.01 nu\1 vitamin C, 34
and of the added vitamin E was 11.8 mM, assuming that
the vitamin E droplet was homogeneously suspended in
the sonicated solution. The concentrations of NADPH,
vitamin E and vitamin C, and the solution conditions
were chosen for experimental convenience. Another set
of control samples which consisted of membranes and
NADPH, vitamin C. or vitamin E at concentrations
equivalent to those stated above. but included no hemolysate was also prepared.

was prewarmed to 37 :!: 0.5°C. The samples were kept
at 4°C. Little spin label reduction was observed at 4°C
over periods of several hours. About I min after the cold
sample was placed in the warm cavity, the sample
temperature reached 37°C, as indicated by a thermocouple inserted in the sample, and the ESR signals were
recorded as a function of time for about 2 h at 37°C,
with spectra taken about every 20 to 30 min. Some ESR
measurements covered a period as long as 22-24 h. For
a few samples, we also monitored the central peak
signal continuously with the following procedures. First
an ESR spectrum was obtained. then the spectrometer
was switched to nonscanning mode to continuously
follow the peak height of the central peak. At a later
time, the spectrometer was switched to the scanning
mode so that a full ESR spectrum was obtained. Then
the spectrometer was returned to the nonscanning mode
to monitor the central peak. Since the full ESR spectrum
was obtained in about 2 min, no noticeable interruption
was detected for the continuous recording of the central
peak height (Fig. 1). The full ESR spectra obtained in
this manner allowed us to check the line-shape and
line-width of the ESR signals during the time period of
the ESR experiments. This approach provided more
accurate measurements of signal reduction, but more
laborious than the one with spectra taken at different
time intervals.
From the ESR spectra, the values of the central peak
height at time t (h,. see Fig. 1) were obtained. Since the
ESR spectra had equivalent line-shapes and line-widths
at different times, the h, values were proportional to the
spin concentrations at time t. Double integrations of the
ESR spectra at different times verified that the spin
concentrations were directly proportional to the peak
height values.
Pseudo first-order rate constants for spin label reduction reactions were obtained from the slope of a linear
regression fit of In (h/h 0 ) versus time plot. where h0
was the initial peak height of ESR spectrum obtained at
t = 0 (see Fig. 1). The SYSTAT (SYSTAT. Incl
statistical personal computer program was used for the
linear regression analysis.

RESULTS AND DISCUSSION

Amoullfs of spin labels
ESR measurements and data analysis
All ESR measurements were done on a Van an E-109
ESR spectrometer with an IBM temperature controller.
A scientific program. ASYST (MacMillan Software),
modified for ESR operation. was used for data acquisitions and data analysis on a Zenith personal computer.
The ESR measurements were made immediately after
the spin-labeled samples were prepared. The ESR cavity

In this study, the ESR signal reduction was fol lowed
as a function of time. At the end of 24 h. only about
5-10% of the signal remained in the spin-labeled red
blood cells. In principle, the higher the initial concentrations of spin label in the erythrocyte membranes. the
more accurately one can follow the decrease in signal
intensities of the spin label at later times. Howe,er.
spin-spin broadening posed an upper limit to the spin
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Fig. I, A typical signal reduction data set for intact red blood cells spin labeled with 5-doxylstearic acid spin label. At time 0 (left-hand side of the
figure), the full spectrum of the spm label was recorded with a central peak height of h,_,. Then the central peak height wa<> foilowed over a pi;:nod
of 2 h (as shown on the top of the figure). The tracing was interrupted occasionally during the 2 h time period to obtain full ESR spectra to check
the line-shape and line-width of the signals. The central peak height at time r was designated as h1• The ESR experiment was done:: at 37cc.

label concentration per cell that could be used for this
study. The spin labels may cluster at higher concentrations to distort the ESR signal. In studies where fatty
acid spin labels were introduced directly into red blood
cell membrane ghosts, the spin labels clustered in
membranes at a spin label-to-lipid weight ratio of about
11400, resulting in spin-spin exchange induced broadening in the ESR spectra. 35 In our study, the line-widths of
the ESR signals were carefully checked, and no spin
broadening was observed in the ESR spectra. The spin
label concentrations were about I. 5 x 10 - 4 M, or
about 8. 7 x 106 spin labels per cell, measured at 4°C,
where reduction was insignificant.

Reduction of 5-doxylstearic acid
In an earlier study of parasitized erythrocytes, spin
label 5-doxylstearic acid was reduced by the electron
transport chain in the parasite, but it was stated that no
reduction was observed in the control, nonparasitized
cells. 23 However, in our studies, we observed consistent
reductions in the ESR signals of CO-gassed, intact
erythrocytes over a period up to 24 h after labeling.
Figure l contains a typical set of spectra showing signal
reduction of the central peak of 5-doxylstearic acid spin
labels in intact cells, in buffer PBS, over a penod of 2 h.
As shown in Fig. l, the three full ESR spectra of the
sample obtained at different time intervals during the
reduction experiment exhibit no change in the ESR
signal line-shape or line-width. Similar reduction was
observed when cells were placed in BSKG buffer.

Reduction of 5-doxylstearic acid spin
intracellular componems

labels

bv

Figure 2 shows a plot of a typical set of data for ESR

signal reduction. At the end of 22 h, for this particular
blood sample, about 95% of the original signal of
5-doxylstearic acid spin labels intercalated in the membranes of CO-gassed intact erythrocytes, in PBS at
37°C, disappeared, with only about 5% signal remaining. Also shown are the retention of signal for the same
spin labels when intercalated in white membrane ghosts
isolated from the same batch of erythrocytes. under the
same experimental conditions as used for intact erythrocytes. No signal reduction was observed over a period of
22 h. When we added about 40 µL hemolysate, prepared from the same batch of blood sample used for
intact cell studies. to the spin-labeled membrane ghosts
samples (about 40 µLat about 4 mg/mL concentration).
we observed signal reductions of about 30% over a
period of 2 h, similar to those observed in intact cells.
shown in Fig. 2 inset for clarity. These data suggest that
intracellular components, which were not present in the
white membrane ghost sample, were responsible for the
signal reductions observed in intact cells.

Reduction rare constants
In order to obtain rate constants from the signal
reduction data presented above, we need to demonstrate
that the spin label translocation rate is relatively faster
than the spin reduction rate in the erythrocytes. When
the fatty acid spin labels are initially introduced to rhe
erythrocyte membranes, they reside in the outer leaflet
of the membrane bilayer. In order for them to be
reduced by intracellular components, the labels must
translocate to the inner leaflet. We monitored the spin
reduction for a system which consisted of labeled intact
ceils plus hemolysate and obtained a reduction rate
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Fig. 2. Percent ESR signal reduction (l-h/h 0 ) over a period of 22 h for spin-labeled intact cells (e). white membrane ghosts<•>. white membrane
ghosts plus hemolysate (.6.), and intact cells plus hemolysate (T). The same batch of blood was used to prepare the samples. The samples were in

5 mM phosphate buffer wich 150 mM NaCl at pH 8.0. The buffer was gassed with carbon monoxide at 4°C before use. For clarity, the data obtained
within the first 2 h were shown in the inset.

similar to that for intact cells (Fig. 2 and inset). If the
translocation movements of the labels in membranes are
slow, relative to ESR measurement time, some labels
would locate in the outer leaflet during the ESR experiments, and we would expect that the addition of
hemolysate to the intact cells would result in a faster
reduction than for intact cells without added hemolysate, since in the sample of intact cells with added
hemolysate, both sides of the bilayer leaflet are in
contact with the "intracellular" components. We found
that the reductions for intact cells and for intact cells
plus hemolysate are similar. We conclude that the
translocation movements of 5-doxylstearic acid spin
labels in erythrocyte membranes are relatively faster
than the spin reduction, and the signal reduction data
can be use to provide reduction rate constants. The
5-doxylstearic acid spin label reduction in many biological systems follows a first-order reaction mechanism. 15 • 18 Our results in intact cells, over time periods of
2 h, exhibit linear fits in semilogarithmic plots, with
correlation coefficients generally > 0.99. A semilogarithmic plot of data for intact RB Cs shown in Fig. I is
illustrated in Fig. 3. The correlation coefficient for the
linear fit was 0. 996. Since the spin label translocation
rate is relatively faster than the spin reduction rate. the
excellent linear fit for signal reduction data exhibited in

Fig. 3 represents a pseudo first-order reduction reaction,
with a rate constant (k) of about 5.1 x 10- 3 /min. As
discussed below, the k values vary from batch to batch
(each batch was defined as the blood sample from one
unit of blood obtained from the blood bank) of blood
samples.
Reproducibility and variability

To check the reliability and reproducibility of the
ESR measurements, we repeated the ESR measurements
of multiple ESR samples prepared from the same spinlabeled samples (group I), and stored at 4°C until the
ESR measurements, which were done at 37°C. We also
prepared multiple spin-labeled samples from the same
batch of blood (group 2) and obtained ESR measurements from these samples. In addition, we obtained
blood samples from different batches (group 3) and
prepared ESR samples in parallel for ESR measurements. We found that the coefficient of variability
(CV) 36 of reduction rate constants, defined as the standard deviations divided by the averaged value of a set of
individual k values, for multiple samples prepared from
one batch of blood (group 1 or 2) was about the same.
Data obtained from 15 batches of blood show that the
CV of individual batches of blood range from 2. l to
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The variation from batch to batch (group 3) was
much larger. The k values from 42 batches of blood
range from l.5 x 10- 3/min to 8.4 x 10- 3/min. with
an average value of 4.3 :!: 1.8 x 10- 3/min. The CV
for batch to batch was about 41.9%.
Table 1 presents a selection of the data from experiments of groups 1 and 2 that exhibit the smallest and the
largest variability coefficients and the data with the
lowest and highest rate constants for samples in groups
1, 2. and 3 .
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Fig. 3. A semilogarithmic plot of the fraction of initial signal
(h/h 0 x 100) versus time for CO-gassed, spin-labeled red blood cells
in PBS. The data were from Fig. l. A linear fit gave a pseudo
first-order rate constant for reduction of abour 5. J x 10- 3/min, with a
correlation coefficient of 0.996.

19.7%, with an average CV of about 9.2 :t 5.9%. This
indicates that the reproducibility of these measurements
are quite good with only about 10% uncertainty in the k
values.

The antioxidant system involves enzymes that scavenge reduced products of oxygen, such as superoxide
dismutase, catalase, glutathione peroxidase, and reduced nicotinamide-adenine dinucleotide (NADH) methemoglobin reductase as well as membrane-associated
vitamin E, vitamin C, intracellular glutathione, and the
reduced pyridine nucleotides (NADH and NADPI-Il. 37 - 39
To test the sensitivity of this method, we have chosen to
alter the concentrations of NADPH, vitamin C, or
vitamin E as examples to modify the antioxidant system.
NADPH is important in providing reducing equivalents
in reactions that are critical in protecting against oxidant
damage. 37 · 38 •40 Vitamin C is an aqueous, intracellular
component, and is known to reduce spin labels in
solution. Vitamin E is membrane-associated, and thus
was also tested.
Figure 4 shows the signal reductions as a function of
time in these treated systems. For the particular batch of

Table l. Reproducibility and Variability of the Pseudo First-Order Rate Constatns for the Reduction of 5Doxylstearic Acid Spin Labels tn CO-Gassed Intact Red Blood Cells. at 37°C
Blood'

Sarnpleb

k'

Averaged k

(10- 3/min)

oo-'1min)

1.5

1.5

Coefficient of
Variability

1.6

4

1.7
1.7

1.7

5.9

4.6
4.7

4.7

2.1

6.1

19.7

7.9

8.1

2.5

8.4

8.4

52
6.9

8.2

6

The averaged coefficient of variability <CV) fork of samples in groups I & 2d from 15 blood batches was
9.2 :t 5.9. The CV for samples in group 3e from 42 blood batches was 41 .9. The averaged rate constant for
42 blood batches was 4.3 :t J .8 x w- '1rrun.
'Each entry under Blood represents one batch of blood from the blood bank.
°Each entry under Sample represents and ESR sample.
ck is the pseudo first order rate constant for spm label reduction.
dSamples in groups I and 2 represent muluple samples prepared from the same batch of blood.
csamples in grouip 3 represent samples prepared from different batches of blood.
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rate constant of about 1.5 x 10- 2/min (data not shown).
The vitamin C and hemolysate effects on spin label reduction appear to be addi1ive. The addition of vitamin
E to samples treated with vitamin C did not further increase the rate constant (data not shown). These data
demonstrated that some of the changes in antioxidant
system affect the reductions of radicals in membranes,
and can be detected by ESR.
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Fig. 4. A semilogarithmic plot of the fraction of initial signal versus
time for 5-dox:ylstearic acid spin labels in samples contammg :!O µL
of white membrane ghosts (4.3 mg/mL). 20 µL CO-gassed hemo!y-

sate and 20 µL of SmM phosphate buffer with 150 mM NaCl at pH
8.0 (j.). IO µL of vitamin E solution (about 70.8 mM) with IO µL
of buffer (shaded star), 20 µL of NADPH solution (2.15 m..\1) Ishaded
diamond), or IO µL of vitamin C solution (20 m.M) with lO µL of
buffer (shaded pentagon). The rate constant obtained for the hemolysate sample was 1.17 x 10- 3/min with a correlation coefficient of
0. 989 for the linear fit. The rate constant for the same blood sample

but with vicamin E was l.:?4 x 10- 3/min, with a correlation coefficient of 0.993. The rate constant for sample with NADPH was 2.57
x 10- 3/min, with a correlation coefficient of0.994, and \\Jth viatrrun
C was 2.76 x 10- 2/min, with a correlation coefficient of 0.997. The
rate constant for sample with vitamin C was determined over a 1ime
periods of Ih.

blood used, the rate constant for the membrane with
hemolysate was 1.17 x 10- 3/min. and the addition of
vitamin E, at a concentration of about 11.8 mM. appeared to have no effect on the reduction of spin labels
in membranes. The rate constant was J.24 x Io- 1/
min, very similar to that without the added vitamin E.
The addition of NADPH to give a final concentration
of 0. 7~ mM enhances the reduction of spin labels 1n
membranes. The rate constant increased to 2. 5 7 x I0 3/min, an increase of about 120%. There was no ESR
signal reduction for membrane samples with or without
similar amounts of NADPH.
Vitamin C, at concentrations of about 3.3 mM. increased the rate constant dramatically, to about 2.76 x
10- 2/min. The rate constant was determined over a time
periods of only 1 h. due to the very rapid reduction in
this system. Sample containing only vitamin C and
membrane also exhibited spin label reducuon. with a

We have used another spin label with the nitroxide
radicals at the 16th carbon positions on the hydrocarbon
chain of the fatty acid (l 6-doxylstearic acid spin label)
as well as 5-doxylstearic acid spin label to demonstrate
that the reduction efficiency of radicals in membranes
by intracellular components is inversely proportional to
the distance of the radical from the surface of the inner
leaflet of the membranes. The same blood samples were
used to prepare the ESR samples needed for this comparison study. Figure 5 shows a typical semilogarithmic
plot of the reductions of 5-doxylstearic acid and 16-doxylstearic acid spin labels in samples obtained from the
same blood sample, as a function of time. The 16-doxylstearic acid has a slower reduction rate (3.6 x 10- 3 /
min) than the 5-doxylstearic acid (6.6 x 10- 3/min).
The rate constant for 16-doxylstearic acid reduction was
almost half the value for 5-doxylstearic acid. This finding demonstrates that it is less efficient to reduce the
more buried radicals in the membranes of intact erythrocytes.

Re-oxidation of 5-doxylstearic acid spin label b\'
oxygen
Our samples were saturated with CO gas to avoid
reoxidation of the spin label by oxygen. If samples were
prepared from 0 2 -gassed buffer rather than CO-gassed
buffer. we observed a slower reduction. in part due to
reoxidation of the spin label from the hydroxylamine
(ESR silent) form back to the nitroxide (ESR active)
form. 4 '
In parallel runs. with the same batch of blood sample, the spin reductions for 0 2 -gassed samples were always lower than the ones for CO-gassed samples. Figure
6 shows the semilogarithmic plot of data obtained from
a typical run of CO- and Orgassed samples. The ESR
signal reduction data of the CO-gassed sample followed
a linear fit with a coefficient of 1.000. The data for the
O,-gassed sample did not give a good linear fit when
data points beyond 90 min were included. since the reduction rate began to decrease due to reoxidation. If we
do not include the data points beyond 90 min. where the
reaction can no longer be described by pseudo
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Fig. 5. A semilogarithmic plot of the fraction of initial signal versus
time for 5-doxylstearic acid spin label (shaded circle), and 16-doxylstearic acid spin label (•) in CO-gassed intact red blood cells. The
rare constant for reduction is 6.6 x I0- 3/min from the linear fir. with
a correlation coefficient of 0.999, for 5-doxylstearic acid spin label,
and 3.6x 10- 3/min. with a correlation coefficient of0.997. for 16doxylstearic acid spin label.

Fig. 6. A semilogarithmic plot of the fraction of initial signal versus
time for 5-doxylsteanc acid spin label in intact red blood cells w1lh
the red blood cells in CO-gassed buffer (shaded circle). or m 0:::gassed buffer<•>· The linear fit gives a rate constant for reduction of
6.4 x 10- 3/min for CO-gassed samples. with a correlauon coefficient
of 1.000, and 3.0X 10- 3/rnin for 0 2 -gassed samples during the first
90-min, with a correlation coefficient of 0.996.

first-order kinetics, the data followed a relatively good
linear fit, with a correlation coefficient of 0.996. From
these linear fits, we obtained a rate constant of 6.-1 x
10- 3/min for the CO-gassed system and 3.0 x
10- 3/min for system under 0 2 atmosphere during the
initial time period of 0-90 min. The average ratio of
k(C0)/k(0 2 ) was 2.4 ± 0.7 for five different paired
experimental runs.
It is important to have erythrocytes fully CO-gassed.
as indicated by the conversion of Hb0 2 to HbCO in intact spin-labeled erythrocytes, before the introduction of
the spin labels to cells. Otherwise. the extent of the spin
label reduction in cells depends on the amount of oxygen in the system.

are obtained from linear fits of semilogarithmic plots of
fraction of initial signal versus time.
When we modified the antioxidant system by adding
excess NADPH, the rate constants were more than
doubled from the values without excess amounts of
NADPH. When fatty acid spin labels with nitroxide
groups at different positions of the hydrocarbon chains
are used, a gradient of the efficiency of the reduction of
radicals at different positions in the hydrocarbon core of
the bilayer can also be determined. The rate constant for
the reduction of spin label radicals at the C 16 position
from the head group of the fatty acid molecule was only
half as high as that at the C5 position. Thus, the pseudo
first-order radical reduction rate constants can be used as
an index for the effectiveness of the antioxidant system
toward radicals in membranes in the erythrocyte.
This method can be applied to RBCs with defective
antioxidant systems, such as those from patients with
blood diseases. This method is particularly useful for
measuring the modification of the antioxidant system
toward radicals in membranes by drugs, chemicals. or
environmental toxins. since the same batch of blood
sample can be used in this case as controls to provide
only about 10% uncertainty in the findings.

COSCLUSIO:"i

We have described a simple spin-labeling method to
measure the antioxidation capacity in membranes of
erythrocytes. This method involves spin labeling Jt>out
30 to 50 µ.L of packed intact erythrocytes in fully COgassed PBS buffer with the commercially avai !able fatty
acid spin label. 5-doxylstearic acid spin label. at .l'C,
and monitoring the ESR signal reduction at J7°C for
about 2 h. Pseudo first-order reduction rate constants
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APPENDIX II

MAJOR ANTIOXIDANTS IN HUMAN RBC

Superoxide Dismutase
SOD was first discovered by McCord and Fridovich in 1969. The enzyme contains
metal and is distributed throughout the various tissues of aerobic organisms.

The

metalloforms of SOD could be CuZnSOD, MnSOD and FeSOD. Human erythrocytes only
contain the CuZnSOD form (Imadaya et al., 1988), which consists of a dimer with one copper
and one zinc per each subunit and has a molecular weight approximately 32,000 daltons. The
role of the zinc (Zn+ 2 ) in SOD is most likely to maintain the stability and organization of the
protein. The copper (Cu+ 2 ) serves as the catalytic center for this enzyme dismutating two
molecules of 0 2 - to form H 2 0 2 and 0 2 • A mechanism involving the copper center is thought
to be as follows (Allen & Bilski, 1982):
cu+ 2 + 0 2 -

--..

Cu+ + 0 2 - + 2H+

Cuo2 +
--+

--+

Cu++ 0 2

Cu+ 2 + H 2 0 2

Since about 3 % of total circulating hemoglobin is converted to methemoglobin per day (Carrel
et al., 1975), and then reduced again by methemoglobin reductase, 0 2 - is continuously

generated in this cycle. A major function of SOD in RBC has been proposed to prevent the
formation of methemoglobin (Lynch et al., 1977). Nevertheless, 0 2 - poses the greatest danger
when it interacts with peroxides to form highly reactive intermediates which can then attack
red cell membrane and cause hemolysis. Therefore, the dismutation of 0 2 - must be very
important to red cells.

Catalase
CAT was named by Loew in 1901 (Percy, 1984 ). It is one of the oldest known
enzymes and present in most aerobic cells, especially concentrated in liver tissues and
erythrocytes. The usual form of CAT has a molecular weight of 240,000 daltons and consists
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of four subunits, each containing a heme [Fe(III)-protoporphyrin] group bound to its active
site. CAT was thought to mediate the detoxification of H 2 0 2 via the following mechanism
(Deisseroth & Dounce, 1970):
P-Fe+ 3 -0H + H 2 0 2

--+

P-Fe+ 3 -00H + H 2 0 2

P-Fe+ 3 -00H + H 2 0

--+

P-Fe+ 3 -0H + H 20 + 0 2

It has been shown that CAT binds four molecules of NADPH (Kirkman & Gaetani,

1984), which is important for the maintenance of its catalytic activity (Eaton et al., 1972;

Gaetani et al., 1989). The reason for existence of high levels of CAT in erythrocyte is not
clear. The argument is based largely on the action of GPx for dispersal of H 2 0 2 (Cohen &
Hochstein, 1963). It is now generally considered that CAT and GPx are both active in
detoxification of H 20 2 in human erythrocytes (Nicholls, 1972; Gaetani et al., 1989).

Glutathione Peroxidase
GPx was first described as an erythrocyte enzyme by Mills in 1957. The enzyme
catalyzes the oxidation of GSH to GSSG at the expense of H 2 0 2 . GPx containing selenium
(Se) is a tetramer with one residue of selenocysteine per mole at each of the active sites and
shows very high activity toward H 2 0 2 as well as organic hydroperoxides. It has a molecular
weight of 84,000 dalton.

There is evidence suggesting that the GPx molecule has a

hydrophobic region which enables it to gain access to LOOH in the membrane and to reduce
them to the corresponding harmless hydroxy fatty acids (LOH) (Chiu et al., 1976; Stults et al.,
1977).

Therefore, GPx is weakly membrane bound and can prevent membrane lipid

peroxidation by catalyzing the reaction (Duchon & Collier, 1971; Ursini & Bindoli, 1987):
LOOH + GSH

--+

LOH + GSSG

GSH, a tripeptide (1-L-glutamyl-L-cysteinylglycine), is required by GPx for the
decomposition of H 20 2 . GSH participates in intracellular redox reactions and also serves as
effective protection against free radicals (Eaton & Brewer, 1974; Barclar, 1988).
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The physiological function of GPx in the erythrocyte seems clear that it protects
hemoglobin from oxidative damage by H 2 0 2 . In addition, GPx also protects hemoglobin from
oxidative damage by a wide variety of hydroperoxides other than H 2 0 2 •

Vitamin E
Vitamin Eis a lipid-soluble molecule composed of four tocopherols (a-, {3-, 1-, and
8- ). It has been shown that a-tocopherol (aTH) is the best antioxidant of the four isomers

(Burton & Ingold, 1981 ). The mode of vitamin E, aTH, action as a free radical scavenger was
first proposed by Tappel ( 1962). It converts lipid peroxyl radicals to the less reactive form
as follows:
LOO· + aTH
LOO· + aT

---+

---+

LOOH + aT
LOOH + aTQ

There is a consensus hypothesis that vitamin E can be regenerated from the
tocopheroxyl radicals (aT) by physiological electron donors such as ascorbic acid and GSH
(Tappel, 1962; Hill & Burk, 1984; Wefers & Sies, 1988; Niki, 1991). However, there remains
some doubts whether the vitamin E regeneration through ascorbic acid or GSH occurs in vivo
(McCay, 1985; Murphy & Kehrer, 1989; Burton et al., 1990).
The major physiological role of vitamin E in human erythrocytes is probably as a
biological antioxidant protecting red cell membranes from peroxidative damage (Chiu et al.,
1982).

Ascorbate
Ascorbate has versatile functions in biological systems such as stimulation of enzymes,
activation of hormones, and facilitation of biosynthesis (Padh, 1990). It has been known that
ascorbate also functions as an antioxidant and radical scavenger to protect oxidative damage
(Machlin & Bendich, 1987).
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Ascorbate is a weak dibasic acid (AH 2 ), with pKa values of 4.2 and 11.8. Therefore,
under physiological conditions, ascorbate anion (AH-) is present predominantly.

AH-

undergoes a two-step oxidation process to form DHA (A), with the formation of ascorbate
free radical A - , as an intermediate (Niki, 1991 ).
AH 2 ---+ AH- + H+
AH- ---+ A-+ H+
A----+ A
The formation of ascorbate free radical may proceed via a hydrogen atom abstraction or by
electron transfer followed by rapid deprotonation, while the former mechanism is believed
to be more favorable (Njus & Kelley, 1991).
Ascorbate functions as an antioxidant by stabilizing active oxygen species that induce
and carry the chain oxidations of biological molecules. Probably the most important reaction
in the inhibition of oxidation by ascorbate may be the scavenging of oxygen radicals such as
superoxide, hydroxyl, hydroperoxyl, lipid peroxyl, and lipid alkoxyl radicals. Under many
types of oxidative stress, ascorbate forms the first line of antioxidant defense (Block et al.,
1991 ).

However, the role of ascorbate in red cells is not completely understood.

In

erythrocytes, ascorbate is considered as a synergist in sparing and maintaining the
concentration of vitamin E to prevent lipid peroxidation (Niki, 1991). On the other hand,
ascorbate has the potential to function as a prooxidant in the presence of ferric ion by
reducing ferric ion to ferrous ion which decomposes peroxides to generate hydroxyl radicals
(Hebbel, 1986).

APPENDIX III

STUDIES OF DENSITY SEPARA TED SICKLE RBC

It is known that red cells from sickle cell anemia patients consist of heterogeneous cell

population and the heterogeneity contributes to cell-to-cell variability in sickling. Due to
different degrees of dehydration, sickle cells have heterogeneous intracellular hemoglobin
concentrations and thus different cell densities.

The most dense cells is enriched with

irreversible sickle cells. Therefore, density gradient separation was used to get cells with more
homogeneous density. The spin label reductions in these density separated cells were studied.

Density Separation of RBC
Washed RBC in BSKG buffer (pH 7.4, osmolality 290 - 300 mmoljkg) were adjusted
to a hematocrit of about 30 %, layered onto a discontinuous stractan density gradient, and
centrifuged at 36,000 rpm (154,000 g) in a swinging bucket rotor for 45 min with
ultracentrifuge. Stractan solution was prepared according to the method of Corash et al.
(1974), as modified by Clark et al. (1976). Briefly, stractan (arabinogalactan) powder was
dissolved in a certain amount of distilled water and the solution was deionized with cationic
and anionic Amberlite to remove impurities and to reduce the osmolality to less than I 00
mmoljkg. Then, stractan solution was adjusted to 290 - 300 mmol/kg by the addition of BSA
(3 g/ 100 ml solution), 0.15 M potassium phosphate butter, pH 7.4 (IO ml/90 ml solution),
MgC1 2 ·6H2 0 (116 mg/100 ml available water), glucose (200 mg/100 ml available water), and
variable amounts of NaCl. The pH of the stractan solution was adjusted to 7.4 with 3 N
NaOH. The solutions of desired densities were made by diluting the stock stractan solution
with BSKG, and the densities of each solution were measured by the use of a digital
densitometer.
After density separation, the two or three fractions of sickle cells were collected by
using transfer pipettes and then washed with CO-gassed PBS buffer three times.
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The

143
unseparated sickle cells which went through stractan were also washed simultaneously. The
same cell labeling procedure and EPR measurement were followed as previously described.

SEM and Cell Dimension Measurements
A drop of washed RBC was fixed by adding a few drops of 2 % glutaraldehyde.
Specimens were then post-fixed on glass slides with two drops of 1 % osmium tetroxide
(Op 4 ) for 3 min, and followed by dehydration in a graded series of aqueous acetone
(30:50:75:95:100 %) and by C0 2 critical point drying with a Polaron E300 Series II critical
point drying apparatus. Specimens were sputtered with gold-palladium using SPI-MODULE
Sputter Coater. The RBC on the slides were examined and selected for picture taking using
ISI-SX-30 Scanning Electron Microscope (SEM). About five fields per sample were analyzed
at magnification of 2,000 times. Approximately 20 to 60 cells were counted for each sample.
The longest diameters of the cells were measured from the SEM pictures with the aid of a
computer light-pen and a computer program (Bioquant II).

Examination of Sample Treatment Effect on Spin Label Reduction
Both PBS (pH 8.0) and BSKG (pH 7.4) isotonic buffers are usually recommended for
erythrocyte suspensions.

PBS was used in this study.

BSKG, stractan, and ultra-

centrifugation were used particularly for the separation of cells according to their densities.
The effects of these treatments of cells on the spin label reduction were examined using the
same batch of normal blood with the following sample treatments: (1) RBC was washed with
PBS; (2) RBC was washed with BSKG and maintained in BSKG for 1 - 2 hr, and washed with
PBS again; (3) RBC was washed with BSKG, mixed with stractan (1.120 g/ml 1 ), maintained
in stractan-BSKG medium for 1 - 2 hr, and finally washed with PBS; (4) RBC was washed

1a

density higher than the normal cells such that cells stayed on the top of stractan.
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with BSKG, then gone through stractan (1.065 g/ml 2 ) by ultracentrifugation, and washed
with PBS afterwards. The labeling and EPR measurements for above samples were carried
out under the same conditions.
The rate constants of spin label reduction from the above four samples were 3.6, 3.9,
4.3 and 3. 7 x l 0- 3 /min, respectively. The average value of the rate constants from these
samples was 3.9 ± 0.3 x 10-3/min, and the CV value was 7. 7 %. This CV value is within the
variation range for the same batch of blood sample shown in Table 1. Therefore, it can be
considered that the spin label reduction rates in RBC were not affected by PBS or BSKG
buffers, stractan, and ultracentrifugation.

Cell Dimension of Density Separated Sickle RBC
In general, volume percentages of different density components varied from patient
to patient, with 70 - 90 % of light (d < 1.120 g/ml), 10 - 15 % of medium (d

=

1.120 - 1.135

g/ml), and 5 - 15 % of dense (d > 1.135 g/ml) cells. Typical SEM pictures of light, medium,
and dense sickle RBC from the same patient are shown in Figure 25. Unseparated sickle RBC
from this patient as well as normal RBC are also shown for comparison. Figure 26 presents
the average values of cell long diameters for unseparated normal and sickle RBC, and
separated sickle RBC of 7 sets of samples. The dense sickle cells had the longest (9.93 ± 1.75
µm) and normal cells had the shortest (6.64 ± 0.30 µm) cell long diameters. The light sickle

cells were a little longer (7 .52 ± 0.44 µm) than normal cells in cell dimension. In addition, the
long diameters of unseparated sickle cells (7.90 ± 0.47 µm) were in between light (7.52 ± 0.44
µm) and medium (8.61 ± 0.98 µm) sickle cells.

2a

density lower than the normal cells such that cells could go through the stractan layer

by ultracentrifugation.
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Figure 25

SEM pictures of unseparated normal and sickle RBC and density separated

sickle RBC. Left upper is unseparated normal cells; Left down is unseparated
sickle cells; Right upper is light sickle cells (d < 1.120 g/ml); Right middle is
medium sickle cells (d = 1.120 - 1.135 g/ml); Right down is dense sickle cells
(d > 1.135 g/ml) cells. Unseparated and separated sickle RBC were from the
same patient. Magnification is about 2,000 times.
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Figure 26

Average cell long diameters for unseparated normal and sickle RBC and
separated sickle RBC. 1. unseparated normal cells; 2. unseparated sickle cells;
3. light sickle cells (d < 1.120 g/ml); 4. medium sickle cells (d

=

1.120 - 1.135

g/ml); 5. dense sickle cells (d > 1.135 g/ml) cells. Data were from seven sets
of samples.
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Reduction Rates of Density Separated Sickle RBC
The spin label reduction rates for light, medium, and dense cells from 6 patients (8
samples) are shown in Figure 27. No clear patterns were observed for the reduction rates of
these light, medium, and dense cells. For the two patients with repeat runs, patient A showed
reproducibility in rate constant measurements and patient B showed large variations within
a set of dense cells. For all 8 samples, the unseparated cells had lower rate constants than the
density separated cells. The rate constants of the light cells were more similar to those of the
unseparated cells. The rate constants of the dense cells were often higher than those of the
light cells (Samples A I, A2, B 1, B2, C 1, and DI).
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Figure 27

Spin label reduction rate constants of unseparated and density separated
sickle RBC. Unseparated sickle cells ( D ); Light sickle cells (d < 1.120 g/ml)

( m); Medium sickle cells (d = 1.120 -

1.135 g/ml) ( Ii ); Dense sickle cells

( d > 1.135 g/ml) cells ( • ). The different letter labels represent different
sickle patients, and the number represents the times of sample run from the
same patient.
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